<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="dmn" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">dmn</book-part-id>
      <title-group>
        <title>Permanent Neonatal Diabetes Mellitus</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>De Le&#x000f3;n</surname>
            <given-names>Diva D</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Associate Professor of Pediatrics <break/>The Children's Hospital of Philadelphia <break/>University of Pennsylvania<break/>Philadelphia, Pennsylvania</aff>
          <email>deleon@email.chop.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Stanley</surname>
            <given-names>Charles A</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Emeritus Professor of Pediatrics <break/>The Children's Hospital of Philadelphia <break/>University of Pennsylvania<break/>Philadelphia, Pennsylvania</aff>
          <email>stanleyc@email.chop.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>8</day>
          <month>2</month>
          <year>2008</year>
        </date>
        <date date-type="updated">
          <day>29</day>
          <month>7</month>
          <year>2016</year>
        </date>
        <date date-type="revised">
          <day>4</day>
          <month>3</month>
          <year>2008</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="pendred" document-type="chapter">Pendred Syndrome/DFNB4</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="pbd" document-type="chapter">Peroxisome Biogenesis Disorders, Zellweger Syndrome Spectrum</related-object>
      <abstract id="dmn.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Permanent neonatal diabetes mellitus (PNDM) is characterized by the onset of hyperglycemia within the first six months of life (mean age: 7 weeks; range: birth to 26 weeks). The diabetes mellitus is associated with partial or complete insulin deficiency. Clinical manifestations at the time of diagnosis include intrauterine growth retardation, hyperglycemia, glycosuria, osmotic polyuria, severe dehydration, and failure to thrive. Therapy with insulin corrects the hyperglycemia and results in dramatic catch-up growth. The course of PNDM varies by genotype.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Persistent hyperglycemia (plasma glucose concentration &#x0003e;150-200 mg/dL) in infants younger than age six months establishes the diagnosis of PNDM. Molecular testing is recommended: identification of pathogenic variant(s) in <italic toggle="yes">ABCC8</italic> or <italic toggle="yes">KCNJ11</italic> can guide treatment.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Start rehydration and intravenous insulin infusion promptly after diagnosis. When the infant is stable and tolerating oral feedings begin subcutaneous insulin therapy. Children with pathogenic variants in <italic toggle="yes">ABCC8</italic> or <italic toggle="yes">KCNJ11</italic> can be treated with oral sulfonylureas; all others require long-term insulin therapy. High caloric intake is necessary for appropriate weight gain. Pancreatic enzyme replacement therapy is required for those with exocrine pancreatic insufficiency.</p>
          <p><italic toggle="yes">Prevention of secondary complications</italic>: Aggressive treatment and frequent monitoring of blood glucose concentrations to avoid acute complications such as diabetic ketoacidosis and hypoglycemia and reduce the long-term complications of diabetes mellitus.</p>
          <p><italic toggle="yes">Surveillance:</italic> Lifelong monitoring of blood glucose concentrations at least four times a day; periodic developmental evaluations. After age ten years, annual screening for chronic complications of diabetes mellitus including urinalysis for microalbuminuria and ophthalmologic examination for retinopathy.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> In general, avoid rapid-acting insulin preparations (lispro and aspart) as well as short-acting (regular) insulin preparations (except as a continuous intravenous or subcutaneous infusion) as they may cause severe hypoglycemia in young children.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>The mode of inheritance of PNDM is autosomal dominant for mutation of <italic toggle="yes">KCNJ11</italic>, autosomal dominant or autosomal recessive for mutation of <italic toggle="yes">ABCC8</italic> and <italic toggle="yes">INS</italic>, and autosomal recessive for mutation of <italic toggle="yes">GCK</italic> and <italic toggle="yes">PDX1</italic>.</p>
          <p>Individuals with autosomal dominant PNDM may have an affected parent or may have a <italic toggle="yes">de novo</italic> pathogenic variant. Each child of an individual with autosomal dominant PNDM has a 50% chance of inheriting the pathogenic variant.</p>
          <p>The parents of a child with autosomal recessive PNDM are obligate heterozygotes and therefore carry one pathogenic variant. Heterozygotes for pathogenic variants in <italic toggle="yes">GCK</italic> and <italic toggle="yes">PDX1</italic> have a mild form of diabetes mellitus known as <italic toggle="yes">GCK</italic>-familial monogenic diabetes (formerly known as MODY2) and <italic toggle="yes">PDX1</italic>-familial monogenic diabetes (formerly known as MODY4). At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier (or of having familial monogenic diabetes), and a 25% chance of being unaffected and not a carrier.</p>
          <p>Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variant(s) in the family are known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="dmn.Diagnosis">
        <title>Diagnosis</title>
        <sec id="dmn.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Permanent neonatal diabetes mellitus (PNDM) <bold>should be suspected</bold> in individuals with the following laboratory and radiographic features:</p>
          <p>
            <bold>Laboratory features</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Persistent hyperglycemia (plasma glucose concentration &#x0003e;150-200 mg/dL) in infants younger than age six months</p>
            </list-item>
            <list-item>
              <p>Features typical of diabetes mellitus (e.g., glucosuria, ketonuria, hyperketonemia)</p>
            </list-item>
            <list-item>
              <p>Low or undetectable plasma insulin and C-peptide relative to the hyperglycemia</p>
            </list-item>
            <list-item>
              <p>Low fecal elastase and high stool fat in infants with pancreatic aplasia or hypoplasia</p>
            </list-item>
          </list>
          <p>Note: Measurement of hemoglobin A1c is not suitable for diagnosing diabetes mellitus in infants younger than age six months because of the higher proportion of fetal hemoglobin compared to hemoglobin A.</p>
          <p>
            <bold>Radiographic features</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Pancreatic hypoplasia identified on ultrasound, CT, or MRI examination</p>
              <p>Note: Visualization of the pancreas in neonates may be difficult; biochemical evidence of pancreatic insufficiency (e.g., low fecal elastase, high stool fat) may help with the diagnosis in these infants.</p>
            </list-item>
          </list>
        </sec>
        <sec id="dmn.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of PNDM <bold>is established</bold> in an infant with diabetes mellitus diagnosed in the first six months of life that does not resolve over time. Molecular testing is recommended: identification of pathogenic variant(s) in one of the genes listed in <xref ref-type="table" rid="dmn.T.molecular_genetic_testing_used_in">Table 1</xref> can guide treatment (see <xref ref-type="sec" rid="dmn.Management">Management</xref>).</p>
          <p>Molecular genetic testing approaches can include <bold>serial single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>.</p>
          <p>
            <bold>Serial single-gene testing</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Individuals with one parent with diabetes mellitus:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Sequence analysis of <italic toggle="yes">KCNJ11</italic> first.</p>
                </list-item>
                <list-item>
                  <p>If no <italic toggle="yes">KCNJ11</italic> pathogenic variant is found, sequence analysis of <italic toggle="yes">ABCC8</italic> and <italic toggle="yes">INS</italic></p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Individuals whose parents both have diabetes mellitus: sequence analysis of <italic toggle="yes">GCK</italic> and <italic toggle="yes">PDX1</italic></p>
            </list-item>
            <list-item>
              <p>Individuals without a family history of diabetes mellitus:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Sequence analysis of <italic toggle="yes">ABCC8</italic> and <italic toggle="yes">KCNJ11</italic> first (as identification of pathogenic variants changes management)</p>
                </list-item>
                <list-item>
                  <p>If no pathogenic variants are identified, sequence analysis of <italic toggle="yes">GCK</italic> and <italic toggle="yes">INS</italic></p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Individuals with pancreatic insufficiency or agenesis without extra-pancreatic abnormalities:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Sequence analysis of <italic toggle="yes">PDX1</italic> first.</p>
                </list-item>
                <list-item>
                  <p>If no pathogenic variants are identified, consider sequence analysis of <italic toggle="yes">PTF1A</italic> [<xref ref-type="bibr" rid="dmn.REF.houghton.2016.2810">Houghton et al 2016</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Individuals with syndromic PNDM: the extrapancreatic characteristics should guide genetic testing (see <xref ref-type="sec" rid="dmn.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</xref> and <xref ref-type="sec" rid="dmn.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
            </list-item>
          </list>
          <p>Note: Deletion/duplication analysis of <italic toggle="yes">GCK</italic>, <italic toggle="yes">INS,</italic>
<italic toggle="yes">PDX1,</italic> and <italic toggle="yes">PTF1A</italic> (and for genes associated with syndromic PNDM) should be considered when sequencing is negative, as homozygous deletions in these genes can be associated with permanent neonatal diabetes mellitus.</p>
          <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">ABCC8</italic>, <italic toggle="yes">GCK</italic>, <italic toggle="yes">INS</italic>, <italic toggle="yes">KCNJ11</italic>, and <italic toggle="yes">PDX1</italic> and other genes of interest (see <xref ref-type="sec" rid="dmn.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Notes: (1) The genes included and the sensitivity of multi-gene panels vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost while limiting secondary findings. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
          <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
          <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">ABCC8</italic>, <italic toggle="yes">GCK</italic>, <italic toggle="yes">INS</italic>, <italic toggle="yes">KCNJ11</italic>, and <italic toggle="yes">PDX1</italic>) fails to confirm a diagnosis in an individual with features of PNDM. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
          <table-wrap id="dmn.T.molecular_genetic_testing_used_in" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Permanent Neonatal Diabetes Mellitus</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_2">Proportion of Permanent Neonatal Diabetes Mellitus Attributed to Pathogenic Variants in This Gene</th>
                  <th id="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Sequence <break/>analysis&#x000a0;<sup>3</sup></th>
                  <th headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ABCC8</italic>
                  </td>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">19%&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">100%</td>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">None reported&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">GCK</italic>
                  </td>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">4%&#x000a0;<sup>8</sup></td>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">100%</td>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">None reported&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">INS</italic>
                  </td>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">20%&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;99%</td>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">1 family&#x000a0;<sup>10</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">KCNJ11</italic>
                  </td>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">30%&#x000a0;<sup>11</sup></td>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">100%</td>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">None reported&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">PDX1</italic>
                  </td>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%&#x000a0;<sup>12</sup></td>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">100%</td>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">None reported&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>13</sup></td>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_2_1 hd_h_dmn.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" colspan="2" align="left" rowspan="1">NA</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="dmn.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="dmn" object-id="dmn.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="dmn.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="dmn.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="dmn.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="dmn.TF.1.4">
                <label>4. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="dmn.TF.1.5">
                <label>5. </label>
                <p>Attributed to activating pathogenic variants of <italic toggle="yes">ABCC8</italic> [<xref ref-type="bibr" rid="dmn.REF.babenko.2006.456">Babenko et al 2006</xref>]</p>
              </fn>
              <fn id="dmn.TF.1.6">
                <label>6. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available.</p>
              </fn>
              <fn id="dmn.TF.1.7">
                <label>7. </label>
                <p>No deletions or duplications involving <italic toggle="yes">ABCC8</italic>, <italic toggle="yes">GCK</italic>, <italic toggle="yes">KCNJ11</italic>, or <italic toggle="yes">PDX1</italic> have been reported to cause permanent neonatal diabetes mellitus. Note that the <italic toggle="yes">KCNJ11</italic> and <italic toggle="yes">ABCC8</italic> defects are activating pathogenic variants and therefore must be missense. Duplication/deletion analysis would not identify <italic toggle="yes">ABCC8</italic> and <italic toggle="yes">KCNJ11</italic> defects.</p>
              </fn>
              <fn id="dmn.TF.1.8">
                <label>8. </label>
                <p><xref ref-type="bibr" rid="dmn.REF.nj_lstad.2001.1588">Nj&#x000f8;lstad et al [2001]</xref>, <xref ref-type="bibr" rid="dmn.REF.nj_lstad.2003.2854">Nj&#x000f8;lstad et al [2003]</xref>. Note: Carrier parents have mild diabetes mellitus or glucose intolerance (<italic toggle="yes">GCK</italic>-familial monogenic diabetes, previously known as MODY2).</p>
              </fn>
              <fn id="dmn.TF.1.9">
                <label>9. </label>
                <p><xref ref-type="bibr" rid="dmn.REF.st_y.2007.15040">St&#x000f8;y et al [2007]</xref>, <xref ref-type="bibr" rid="dmn.REF.polak.2008.1115">Polak et al [2008]</xref></p>
              </fn>
              <fn id="dmn.TF.1.10">
                <label>10. </label>
                <p>A 646-bp deletion in <italic toggle="yes">INS</italic> was reported in individuals with neonatal diabetes [<xref ref-type="bibr" rid="dmn.REF.raile.2011.255">Raile et al 2011</xref>, <xref ref-type="bibr" rid="dmn.REF.garin.2010.3105">Garin et al 2010</xref>, <xref ref-type="bibr" rid="dmn.REF.st_y.2010.205">St&#x000f8;y et al 2010</xref>]; see <xref ref-type="table" rid="dmn.T.selected_ins_pathogenic_variants">Table 5</xref>.</p>
              </fn>
              <fn id="dmn.TF.1.11">
                <label>11. </label>
                <p>Attributed to activating pathogenic variants in <italic toggle="yes">KCNJ11</italic> [<xref ref-type="bibr" rid="dmn.REF.ellard.2007.375">Ellard et al 2007</xref>]</p>
              </fn>
              <fn id="dmn.TF.1.12">
                <label>12. </label>
                <p>Attributed to inactivating pathogenic variants [<xref ref-type="bibr" rid="dmn.REF.stoffers.1997a.138">Stoffers et al 1997a</xref>]. Note: Carrier parents have mild, adult-onset diabetes mellitus (<italic toggle="yes">PDX1</italic>-familial monogenic diabetes, previously known as MODY4).</p>
              </fn>
              <fn id="dmn.TF.1.13">
                <label>13. </label>
                <p>The genetic causes of approximately 30% of PNDM remain unknown [<xref ref-type="bibr" rid="dmn.REF.rubiocabezas.2014.47">Rubio-Cabezas et al 2014</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="dmn.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="dmn.Clinical_Description">
          <title>Clinical Description</title>
          <p>Permanent neonatal diabetes mellitus (PNDM) is characterized by the onset of hyperglycemia within the first six months of life with a mean age at diagnosis of seven weeks (range: birth to 26 weeks) [<xref ref-type="bibr" rid="dmn.REF.gloyn.2004b.1838">Gloyn et al 2004b</xref>].</p>
          <p>The diabetes mellitus is associated with partial or complete insulin deficiency.</p>
          <p>Clinical manifestations at diagnosis include intrauterine growth retardation (IUGR; a reflection of insulin deficiency in utero), hyperglycemia, glycosuria, osmotic polyuria, severe dehydration, and failure to thrive.</p>
          <p>Therapy with insulin corrects the hyperglycemia and results in dramatic catch-up growth.</p>
        </sec>
        <sec id="dmn.Phenotype_Correlations_by_Gene">
          <title>Phenotype Correlations by Gene</title>
          <p>The course of PNDM is highly variable depending on the genotype.</p>
          <p><bold><italic toggle="yes">ABCC8</italic> and <italic toggle="yes">KCNJ11</italic>.</bold> Most individuals with PNDM caused by pathogenic variants in <italic toggle="yes">ABCC8</italic> and <italic toggle="yes">KCNJ11</italic> are diagnosed before age three months, but a few present in childhood or early adult life. The majority of affected infants have low birth weight resulting from lower fetal insulin production. The typical presentation is symptomatic hyperglycemia, and in many individuals, ketoacidosis.</p>
          <p>Although most individuals with pathogenic variants in <italic toggle="yes">KCNJ11</italic> have isolated diabetes, 20% have associated neurologic features, called DEND syndrome (<italic toggle="yes">d</italic>evelopmental delay, <italic toggle="yes">e</italic>pilepsy, and <italic toggle="yes">n</italic>eonatal <italic toggle="yes">d</italic>iabetes mellitus) [<xref ref-type="bibr" rid="dmn.REF.hattersley.2006.352">Hattersley et al 2006</xref>]. A milder form, called intermediate DEND syndrome, presents with less severe developmental delay and without epilepsy. In individuals with <italic toggle="yes">KCNJ11</italic> pathogenic variants, treatment with sulfonylureas corrects the hyperglycemia [<xref ref-type="bibr" rid="dmn.REF.pearson.2006.467">Pearson et al 2006</xref>] and may reverse some of the neurologic manifestations [<xref ref-type="bibr" rid="dmn.REF.hattersley.2005.2503">Hattersley &#x00026; Ashcroft 2005</xref>, <xref ref-type="bibr" rid="dmn.REF.slingerland.2006.2559">Slingerland et al 2006</xref>]. Neurologic manifestations might be prevented by early treatment with these agents [<xref ref-type="bibr" rid="dmn.REF.greeley.2010.464">Greeley et al 2010</xref>] (see <xref ref-type="sec" rid="dmn.Management">Management</xref>).</p>
          <p><bold><italic toggle="yes">GCK</italic>.</bold> PNDM caused by biallelic <italic toggle="yes">GCK</italic> pathogenic variants is characterized by IUGR, insulin-requiring diabetes from the first day of life, and hyperglycemia in both parents.</p>
          <p><bold><italic toggle="yes">INS</italic>.</bold> Individuals with PNDM caused by heterozygous <italic toggle="yes">INS</italic> pathogenic variants or biallelic deletions of <italic toggle="yes">INS</italic> present with diabetic ketoacidosis or marked hyperglycemia. Most newborns are small for gestational age [<xref ref-type="bibr" rid="dmn.REF.st_y.2007.15040">St&#x000f8;y et al 2007</xref>, <xref ref-type="bibr" rid="dmn.REF.polak.2008.1115">Polak et al 2008</xref>]. The median age at diagnosis is nine weeks, but some children present after age six months [<xref ref-type="bibr" rid="dmn.REF.edghill.2008.1034">Edghill et al 2008</xref>].</p>
          <p><bold><italic toggle="yes">PDX1</italic>.</bold> Pancreatic hypoplasia caused by biallelic <italic toggle="yes">PDX1</italic> pathogenic variants results in a more severe insulin deficiency than in <italic toggle="yes">ABCC8, GCK, or KCNJ11</italic>-related neonatal diabetes as shown by a lower birth weight and a younger age at diagnosis. These individuals also have exocrine pancreatic insufficiency.</p>
        </sec>
        <sec id="dmn.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><bold><italic toggle="yes">ABCC8.</italic></bold> For neonatal diabetes caused by pathogenic variants in <italic toggle="yes">ABCC8</italic>, genotype-phenotype correlations are less distinct [<xref ref-type="bibr" rid="dmn.REF.edghill.2010.193">Edghill et al 2010</xref>]. Children with neonatal diabetes associated with dominant <italic toggle="yes">ABCC8</italic> pathogenic variants may have a parent with the same <italic toggle="yes">ABCC8</italic> variant and type 2 diabetes, suggesting that the severity of the phenotype and age of onset of diabetes is variable among individuals with <italic toggle="yes">ABCC8</italic> pathogenic variants [<xref ref-type="bibr" rid="dmn.REF.babenko.2006.456">Babenko et al 2006</xref>].</p>
          <p><bold><italic toggle="yes">INS</italic>.</bold> The relationship between genotype and phenotype is beginning to emerge for NDM caused by pathogenic variants in <italic toggle="yes">INS</italic>. The diabetes mellitus in persons who are homozygous or compound heterozygous for pathogenic variants in <italic toggle="yes">INS</italic> can be permanent or transient. The variants <xref ref-type="table" rid="dmn.T.selected_ins_pathogenic_variants">c.-366_343del</xref>, <xref ref-type="table" rid="dmn.T.selected_ins_pathogenic_variants">c.3G&#x0003e;A</xref>, <xref ref-type="table" rid="dmn.T.selected_ins_pathogenic_variants">c.3G&#x0003e;T</xref>, <xref ref-type="table" rid="dmn.T.selected_ins_pathogenic_variants">c.184C&#x0003e;T</xref>, <xref ref-type="table" rid="dmn.T.selected_ins_pathogenic_variants">c.-370-?186+?del</xref> (a 646-bp deletion) and <xref ref-type="table" rid="dmn.T.selected_ins_pathogenic_variants">c.*59A&#x0003e;G</xref> appear to be associated with PNDM, whereas the variants <xref ref-type="table" rid="dmn.T.selected_ins_pathogenic_variants">c.-218A&#x0003e;C</xref> and <xref ref-type="table" rid="dmn.T.selected_ins_pathogenic_variants">c.-331C&#x0003e;A</xref> or <xref ref-type="table" rid="dmn.T.selected_ins_pathogenic_variants">c.-331C&#x0003e;G</xref> have been identified in persons with both PNDM and TNDM as well as persons with type 1b diabetes mellitus [<xref ref-type="bibr" rid="dmn.REF.st_y.2010.205">St&#x000f8;y et al 2010</xref>].</p>
          <p><bold><italic toggle="yes">KCNJ11</italic>.</bold> Clear genotype-phenotype correlations exist for those forms of PNDM associated with <italic toggle="yes">KCNJ11</italic> pathogenic variants.</p>
          <p>Genotype-phenotype studies correlate <italic toggle="yes">KCNJ11</italic> pathogenic variants and phenotype with the extent of reduction in K<sub>ATP</sub> channel ATP sensitivity.</p>
          <p>Some <italic toggle="yes">KCNJ11</italic> pathogenic variants are associated with transient neonatal diabetes mellitus (TNDM); others are associated with PNDM; and two variants, <xref ref-type="table" rid="dmn.T.selected_kcnj11_variants">p.Val252Ala</xref> and <xref ref-type="table" rid="dmn.T.selected_kcnj11_variants">p.Arg201His</xref>, are associated with both disorders [<xref ref-type="bibr" rid="dmn.REF.colombo.2005.2439">Colombo et al 2005</xref>, <xref ref-type="bibr" rid="dmn.REF.girard.2006.323">Girard et al 2006</xref>]. Furthermore, functional studies have shown some overlap between the magnitude of the K<sub>ATP</sub> channel currents in TNDM- and PNDM-associated pathogenic variants [<xref ref-type="bibr" rid="dmn.REF.girard.2006.323">Girard et al 2006</xref>].</p>
          <p>The location of the <italic toggle="yes">KCNJ11</italic> pathogenic variant appears to predict the severity of the disease (isolated diabetes mellitus, intermediate DEND syndrome, DEND syndrome), however, there are some exceptions. Pathogenic variants in residues that lie within the putative ATP-binding site (Arg50, Ile192, Leu164, Arg201, Phe333) or are located at the interfaces between Kir6.2 subunits (Phe35, Cys42, and Gu332) or between Kir6.2 and <italic toggle="yes">SUR1</italic> (Gly53) are associated with isolated diabetes mellitus. See <xref ref-type="sec" rid="dmn.Molecular_Genetics">Molecular Genetics</xref>, <bold><italic toggle="yes">KCNJ11</italic></bold>, <bold>Normal gene product</bold> for a discussion of Kir6.2 and <bold><italic toggle="yes">ABCC8,</italic> Normal gene product for Sur1.</bold></p>
          <p>The severity of PNDM along the spectrum of isolated diabetes mellitus, intermediate DEND syndrome, and DEND syndrome correlates with the genotype [<xref ref-type="bibr" rid="dmn.REF.proks.2004.17539">Proks et al 2004</xref>]. <italic toggle="yes">KCNJ11</italic> variants that cause additional neurologic features occur at codons for amino acid residues that lie at some distance from the ATP-binding site (Gln52, Gly53, Val59, Cys166, and Ile296) [<xref ref-type="bibr" rid="dmn.REF.hattersley.2005.2503">Hattersley &#x00026; Ashcroft 2005</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>Of 24 individuals with pathogenic variants at the arginine residue, Arg201, all but three had isolated PNDM.</p>
            </list-item>
            <list-item>
              <p>The <xref ref-type="table" rid="dmn.T.selected_kcnj11_variants">p.Val59Met</xref> variant is associated with intermediate DEND syndrome.</p>
            </list-item>
            <list-item>
              <p>The following pathogenic variants associated with DEND syndrome are not found in less severely affected individuals: <xref ref-type="table" rid="dmn.T.selected_kcnj11_variants">p.Gln52Arg</xref>, <xref ref-type="table" rid="dmn.T.selected_kcnj11_variants">p.Val59Gly</xref>, <xref ref-type="table" rid="dmn.T.selected_kcnj11_variants">p.Ile296Val</xref>, <xref ref-type="table" rid="dmn.T.selected_kcnj11_variants">p.Cys166Phe</xref> [<xref ref-type="bibr" rid="dmn.REF.gloyn.2006.824">Gloyn et al 2006</xref>], p.Gly334Asp [<xref ref-type="bibr" rid="dmn.REF.masia.2007b.328">Masia et al 2007b</xref>], <xref ref-type="table" rid="dmn.T.selected_kcnj11_variants">p.Ile167Leu</xref> [<xref ref-type="bibr" rid="dmn.REF.shimomura.2007.1342">Shimomura et al 2007</xref>], <xref ref-type="table" rid="dmn.T.selected_kcnj11_variants">p.Gly53Asp</xref>, <xref ref-type="table" rid="dmn.T.selected_kcnj11_variants">p.Cys166Tyr</xref>, and <xref ref-type="table" rid="dmn.T.selected_kcnj11_variants">p.Ile296Leu</xref> [<xref ref-type="bibr" rid="dmn.REF.flanagan.2006.1190">Flanagan et al 2006</xref>].</p>
            </list-item>
            <list-item>
              <p>Improvement of the neurologic features of DEND syndrome with sulfonylurea treatment also appears to be genotype dependent: children with the variants <xref ref-type="table" rid="dmn.T.selected_kcnj11_variants">p.Val59Met</xref> [<xref ref-type="bibr" rid="dmn.REF.st_y.2008.450">St&#x000f8;y et al 2008</xref>, <xref ref-type="bibr" rid="dmn.REF.mohamadi.2010.203">Mohamadi et al 2010</xref>] and <xref ref-type="table" rid="dmn.T.selected_kcnj11_variants">p.Gly53Asp</xref> [<xref ref-type="bibr" rid="dmn.REF.koster.2008.1054">Koster et al 2008</xref>] have been shown to respond to sulfonylureas.</p>
            </list-item>
          </list>
        </sec>
        <sec id="dmn.Penetrance">
          <title>Penetrance</title>
          <p>Reduced penetrance has been seen in PNDM caused by pathogenic variants in <italic toggle="yes">KCNJ11</italic> and <italic toggle="yes">ABCC8</italic> [<xref ref-type="bibr" rid="dmn.REF.flanagan.2007.1930">Flanagan et al 2007</xref>].</p>
        </sec>
        <sec id="dmn.Nomenclature">
          <title>Nomenclature</title>
          <p>Some individuals with "neonatal" diabetes mellitus may not be diagnosed until age three to six months, therefore it has been suggested that the term "diabetes mellitus of infancy" or &#x0201c;congenital diabetes&#x0201d; should replace the designation "neonatal diabetes mellitus" [<xref ref-type="bibr" rid="dmn.REF.massa.2005.22">Massa et al 2005</xref>, <xref ref-type="bibr" rid="dmn.REF.greeley.2011.519">Greeley et al 2011</xref>].</p>
        </sec>
        <sec id="dmn.Prevalence">
          <title>Prevalence</title>
          <p>The estimated incidence of permanent neonatal diabetes ranges from 1:215,000 to 1:260,000 live births [<xref ref-type="bibr" rid="dmn.REF.stanik.2007.1276">Stanik et al 2007</xref>, <xref ref-type="bibr" rid="dmn.REF.slingerland.2009.1683">Slingerland et al 2009</xref>, <xref ref-type="bibr" rid="dmn.REF.wiedemann.2010.18">Wiedemann et al 2010</xref>].</p>
        </sec>
      </sec>
      <sec id="dmn.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold><italic toggle="yes">ABCC8, GCK,</italic> and <italic toggle="yes">KCNJ11</italic>.</bold> Pathogenic variants in <italic toggle="yes">ABCC8</italic>, <italic toggle="yes">GCK</italic> and <italic toggle="yes">KCNJ11</italic> are known to be associated with <related-object link-type="booklink" source-id="gene" document-id="hi" document-type="chapter">familial hyperinsulinism</related-object> (FHI). FHI is characterized by hypoglycemia that ranges from severe, difficult-to-manage neonatal-onset disease to childhood-onset disease with mild symptoms and difficult-to-diagnose hypoglycemia. Neonatal-onset disease manifests within hours to one to two days after birth; childhood-onset disease manifests during the first months or years of life. FHI caused by pathogenic variants in either <italic toggle="yes">ABCC8</italic> or <italic toggle="yes">KCNJ11</italic> (FHI-K<sub>ATP</sub>) is most commonly inherited in an autosomal recessive manner and less commonly in an autosomal dominant manner. FHI caused by pathogenic variants in <italic toggle="yes">GCK</italic> is inherited in an autosomal dominant manner. Infants with GCK-related FHI tend to be large for gestational age at birth and may present in early infancy (range: 2 days to 30 years).</p>
        <p>
          <bold><italic toggle="yes">ABCC8</italic> and <italic toggle="yes">KCNJ11</italic></bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Common variants</bold> in <italic toggle="yes">ABCC8</italic> and <italic toggle="yes">KCNJ11</italic>, particularly <xref ref-type="table" rid="dmn.T.selected_kcnj11_variants">p.Glu23Lys</xref> in <italic toggle="yes">KCNJ11</italic>, have been associated with type 2 diabetes mellitus [<xref ref-type="bibr" rid="dmn.REF.hani.1998.1511">Hani et al 1998</xref>, <xref ref-type="bibr" rid="dmn.REF.gloyn.2001.206">Gloyn et al 2001</xref>, <xref ref-type="bibr" rid="dmn.REF.hansen.2001.1330">Hansen et al 2001</xref>, <xref ref-type="bibr" rid="dmn.REF.hart.2002.3135">Hart et al 2002</xref>, <xref ref-type="bibr" rid="dmn.REF.gloyn.2003.568">Gloyn et al 2003</xref>, <xref ref-type="bibr" rid="dmn.REF.nielsen.2003.573">Nielsen et al 2003</xref>, <xref ref-type="bibr" rid="dmn.REF.florez.2004.1360">Florez et al 2004</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Activating pathogenic variants</bold> in <italic toggle="yes">ABCC8</italic> and <italic toggle="yes">KCNJ11</italic> with less severe effects on channel function have been found to cause TNDM that is similar to the biphasic course seen in the 6q24-related TNDM phenotype. Typically, infants with TNDM caused by K<sub>ATP</sub> channel pathogenic variants present before age six months, then go into remission between ages six and 12 months and are likely to relapse during adolescence or early adulthood [<xref ref-type="bibr" rid="dmn.REF.gloyn.2005.925">Gloyn et al 2005</xref>, <xref ref-type="bibr" rid="dmn.REF.flanagan.2007.1930">Flanagan et al 2007</xref>].</p>
          </list-item>
        </list>
        <p><bold><italic toggle="yes">ABCC8</italic>.</bold> A dominant <italic toggle="yes">ABCC8</italic> pathogenic variant is associated with hyperinsulinemic hypoglycemia in the neonatal period and may lead to diabetes mellitus later in life [<xref ref-type="bibr" rid="dmn.REF.huopio.2003.301">Huopio et al 2003</xref>].</p>
        <p><bold><italic toggle="yes">GCK</italic>.</bold> Dominant inactivating pathogenic variants in <italic toggle="yes">GCK</italic> are associated with <italic toggle="yes">GCK</italic>-familial monogenic diabetes, a mild form of diabetes mellitus presenting later in life.</p>
        <p><bold><italic toggle="yes">INS.</italic></bold> Heterozygous pathogenic variants in <italic toggle="yes">INS</italic> have been reported in individuals with infancy-onset diabetes, type 1b (antibody negative) diabetes, familial monogenic diabetes and early-onset type 2 diabetes [<xref ref-type="bibr" rid="dmn.REF.st_y.2010.205">St&#x000f8;y et al 2010</xref>].</p>
        <p><bold><italic toggle="yes">KCNJ11.</italic></bold> A subset of individuals with biallelic pathogenic variants in <italic toggle="yes">KCNJ11</italic> will present with transient instead of permanent neonatal diabetes mellitus (see <xref ref-type="sec" rid="dmn.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
        <p><bold><italic toggle="yes">PDX1</italic>.</bold> Dominant inactivating pathogenic variants of <italic toggle="yes">PDX1</italic> are associated with <italic toggle="yes">PDX1</italic>-familial monogenic diabetes, a mild form of diabetes mellitus.</p>
      </sec>
      <sec id="dmn.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Permanent neonatal diabetes mellitus (PNDM) vs transient neonatal diabetes mellitus (TNDM).</bold> When diabetes mellitus is diagnosed in the neonatal period, it is difficult to determine if it is likely to be transient or permanent.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="dmtn" document-type="chapter">6q24-related TNDM</related-object> is defined as transient neonatal diabetes mellitus caused by overexpression of the imprinted genes at 6q24 (<italic toggle="yes">PLAGL1</italic> and <italic toggle="yes">HYMAI</italic>). The cardinal features are: severe intrauterine growth retardation, hyperglycemia that begins in the neonatal period in a term infant and resolves by age 18 months, dehydration, and absence of ketoacidosis. Macroglossia and umbilical hernia are often present. In the subset of children with <italic toggle="yes">ZFP57</italic> pathogenic variants, other manifestations can include structural brain abnormalities, developmental delay, and congenital heart disease. Diabetes mellitus usually starts within the first week of life and lasts on average three months but can last more than a year. Although insulin is usually required initially, the need for insulin gradually declines over time. Intermittent episodes of hyperglycemia may occur in childhood, particularly during intercurrent illnesses. Recurrence in adolescence is more akin to type 2 diabetes mellitus. Relapse in women during pregnancy is associated with gestational diabetes mellitus.</p>
        <p>The two most common causes of transient neonatal diabetes are 6q24-related TNDM and pathogenic variants in <italic toggle="yes">ABCC8</italic> or <italic toggle="yes">KCNJ11</italic>. In 50 children presenting with neonatal diabetes, <xref ref-type="bibr" rid="dmn.REF.metz.2002.483">Metz et al [2002]</xref> failed to demonstrate clear clinical indicators to differentiate 6q24-related TNDM from other causes. However, the clinical presentation may be slightly different: neonates with 6q24-related TNDM have more severe intrauterine growth retardation, present earlier, remit earlier, and relapse later than K<sub>ATP</sub>-related TNMD. The presence of other distinguishing features of 6q24-related TNDM may guide the approach to genetic testing, such macroglossia (seen in 1/3 of patients) and umbilical hernia [<xref ref-type="bibr" rid="dmn.REF.rubiocabezas.2014.47">Rubio-Cabezas et al 2014</xref>].</p>
        <list list-type="bullet">
          <list-item>
            <p>For infants presenting in the first two weeks of life, it is reasonable to test for 6q24-related aberrations first, followed by testing for <italic toggle="yes">KCNJ11</italic> and <italic toggle="yes">ABCC8</italic> pathogenic variants.</p>
          </list-item>
          <list-item>
            <p>For infants presenting from the third week of life onward, it may be more appropriate to test for <italic toggle="yes">KCNJ11</italic> and <italic toggle="yes">ABCC8</italic> pathogenic variants first, followed by testing for 6q24-related aberrations.</p>
          </list-item>
          <list-item>
            <p>In infants presenting between age six and 12 months or later who are antibody negative or have a family history consistent with autosomal dominant inheritance, evaluation for pathogenic variants in <italic toggle="yes">INS</italic> should be considered first.</p>
          </list-item>
        </list>
        <p>For infants with associated extra-pancreatic features or consanguineous parents, other genetic analysis may be appropriate.</p>
        <p>
          <bold>Syndromic causes of permanent neonatal diabetes mellitus</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><bold><italic toggle="yes">GATA4</italic>-related PNDM.</bold> Heterozygous inactivating pathogenic variants in <italic toggle="yes">GATA4</italic> are associated with pancreatic agenesis or pancreatic hypoplasia leading to PNDM and congenital heart defects [<xref ref-type="bibr" rid="dmn.REF.d_amato.2010.1195">D&#x02019;Amato et al 2010</xref>, <xref ref-type="bibr" rid="dmn.REF.shawsmith.2014.2888">Shaw-Smith et al 2014</xref>]. GATA4 is a zinc finger transcription factor closely related to GATA6. The diabetes phenotype in individual carrying pathogenic variants is quite variable, ranging from TNDM, PNDM and diabetes presenting later in life. The severity of the exocrine insufficiency is also variable. Extrapancreatic manifestations include cardiac abnormalities and neurodevelopmental delays. Inheritance is autosomal dominant, but in most reported individuals the pathogenic variants have arisen <italic toggle="yes">de novo</italic>.</p>
          </list-item>
          <list-item>
            <p><bold><italic toggle="yes">GATA6-</italic>related PNDM</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/600001">600001</ext-link>). Heterozygous inactivating pathogenic variants in <italic toggle="yes">GATA6</italic> are the most common cause of pancreatic agenesis [<xref ref-type="bibr" rid="dmn.REF.lango_allen.2011.20">Lango Allen et al 2011</xref>]. Extrapancreatic features are common and include structural heart defects, biliary tract and gut anomalies, and other endocrine abnormalities. The diabetic phenotype in those with pathogenic variants in <italic toggle="yes">GATA6</italic> is broad, ranging from PNDM with exocrine insufficiency to transient episodes of hyperglycemia. In the largest published series of <italic toggle="yes">GATA6</italic>-PNDM, the median age at diagnosis of diabetes was two days and the median birth weight was 1588 grams. Individuals with heterozygous pathogenic variants in <italic toggle="yes">GATA6</italic> have also been diagnosed with diabetes at an older age [<xref ref-type="bibr" rid="dmn.REF.lango_allen.2011.20">Lango Allen et al 2011</xref>, <xref ref-type="bibr" rid="dmn.REF.de_franco.2013.993">De Franco et al 2013</xref>]. Inheritance is autosomal dominant, but in most reported individuals the pathogenic variants have arisen <italic toggle="yes">de novo</italic>.</p>
          </list-item>
          <list-item>
            <p><bold><italic toggle="yes">PTF1A</italic>-related PNDM</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/609069">609069</ext-link>). Homozygous inactivating pathogenic variants in <italic toggle="yes">PTF1A</italic> cause pancreatic agenesis leading to PNDM associated with cerebellar agenesis and severe neurologic dysfunction [<xref ref-type="bibr" rid="dmn.REF.sellick.2004.1301">Sellick et al 2004</xref>]. <italic toggle="yes">PTF1A</italic> encodes a basic helix-loop-helix protein of 48 kD. The protein plays a role in determining whether cells allocated to the pancreatic buds continue toward pancreatic organogenesis or revert back to duodenal fates [<xref ref-type="bibr" rid="dmn.REF.kawaguchi.2002.128">Kawaguchi et al 2002</xref>]. Infants with <italic toggle="yes">PTF1A</italic>-related PNDM present with severe IUGR, and very low circulating insulin and C-peptide in the presence of severe hyperglycemia. Neurologic features include flexion contractures of extremities and absence of the cerebellum demonstrated on brain imaging [<xref ref-type="bibr" rid="dmn.REF.sellick.2004.1301">Sellick et al 2004</xref>]. A recent report described an individual with <italic toggle="yes">PTF1A</italic>-related PNDM without neurological manifestations [<xref ref-type="bibr" rid="dmn.REF.houghton.2016.2810">Houghton et al 2016</xref>]. Exocrine pancreatic dysfunction may be present as well. Inheritance is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="ipex" document-type="chapter"><bold>Immune dysregulation, polyendocrinopathy, and enteropathy, X-linked (IPEX) syndrome</bold></related-object> is characterized by the development of overwhelming systemic autoimmunity in the first year of life resulting in the commonly observed triad of watery diarrhea, eczematous dermatitis, and endocrinopathy seen most commonly as insulin-dependent diabetes mellitus. The majority of affected males have other autoimmune phenomena including Coombs-positive anemia, autoimmune thrombocytopenia, autoimmune neutropenia, and tubular nephropathy. Typically, serum concentration of immunoglobulin E (IgE) is elevated. The majority of affected males die within the first year of life of either metabolic derangements or sepsis. <italic toggle="yes">FOXP3</italic> is currently the only gene in which mutation is known to cause IPEX syndrome. Inheritance is X-linked.</p>
          </list-item>
          <list-item>
            <p><bold>Wolcott-Rallison syndrome</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/226980">226980</ext-link>) is characterized by infantile-onset diabetes mellitus and exocrine pancreatic dysfunction (25%) as well as the extra-pancreatic manifestations of epiphyseal dysplasia (90%), developmental delay (80%), acute liver failure (75%), osteopenia (50%), and hypothyroidism (25%). In addition, older individuals with Wolcott-Rallison syndrome may develop chronic kidney dysfunction [<xref ref-type="bibr" rid="dmn.REF.sen_e.2004.1876">Sen&#x000e9;e et al 2004</xref>]. The prognosis is poor. <italic toggle="yes">EIF2AK3</italic>, the gene encoding eukaryotic translation initiation factor 2-alpha kinase 3, is the only gene in which pathogenic variants are known to cause Wolcott-Rallison syndrome. <xref ref-type="bibr" rid="dmn.REF.durocher.2006.34">Durocher et al [2006]</xref> observed that the severity of the manifestations and age of presentation in individuals with the same pathogenic variant may vary and concluded that no simple relationship exists between the clinical manifestation and <italic toggle="yes">EIF2AK3</italic> pathogenic variants in Wolcott-Rallison syndrome. This is the most common cause of PNDM in consanguineous families [<xref ref-type="bibr" rid="dmn.REF.rubiocabezas.2009.4162">Rubio-Cabezas et al 2009</xref>]. Inheritance is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><bold>A syndrome of neonatal diabetes mellitus with congenital hypothyroidism</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/610199">610199</ext-link>) has been associated with mutation of <italic toggle="yes">GLIS3</italic>. <italic toggle="yes">GLIS3</italic> encodes zinc finger protein GLIS3 (also known as GLI similar protein 3), a transcription factor expressed in the pancreas from early developmental stages. GLIS3 plays a role in the transcriptional regulation of neurogenin-3 and insulin [<xref ref-type="bibr" rid="dmn.REF.kim.2012.193">Kim et al 2012</xref>, <xref ref-type="bibr" rid="dmn.REF.zeruth.2013.1692">ZeRuth et al 2013</xref>]. In addition to neonatal diabetes and congenital hypothyroidism, the syndrome can present with congenital glaucoma, hepatic fibrosis, polycystic kidneys, and dysmorphic facial features [<xref ref-type="bibr" rid="dmn.REF.sen_e.2006.682">Sen&#x000e9;e et al 2006</xref>]. Inheritance is autosomal recessive and partial gene deletions are the most common type of pathogenic variant [<xref ref-type="bibr" rid="dmn.REF.dimitri.2011.437">Dimitri et al 2011</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>A syndrome of neonatal diabetes mellitus with pancreatic hypoplasia, intestinal atresia, and gall bladder hypoplasia</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/615710">615710</ext-link>) has been associated with pathogenic variants in <italic toggle="yes">RFX6</italic>. RFX6 is a transcription factor required for the differentiation of four of the five islet cell types and for the production of insulin. RFX6 acts downstream of the pro-endocrine factor neurogenin-3. Pancreatic exocrine function is normal [<xref ref-type="bibr" rid="dmn.REF.smith.2010.775">Smith et al 2010</xref>]. Inheritance is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><bold>A syndrome of neonatal diabetes mellitus, cerebellar hypoplasia, sensorineural deafness, and visual impairment</bold> has been associated with pathogenic variants in <italic toggle="yes">NEUROD1</italic> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/601724">601724</ext-link>), encoding neurogenic differentation factor 1, a transcription factor that plays an important role in the development of the endocrine pancreas. Pancreatic exocrine function is normal [<xref ref-type="bibr" rid="dmn.REF.rubiocabezas.2010.2326">Rubio-Cabezas et al 2010</xref>]. Inheritance is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><bold>A</bold>
<bold>syndrome of congenital malabsorptive diarrhea and neonatal diabetes mellitus</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/610370">610370</ext-link>) has been associated with pathogenic variants in <italic toggle="yes">NEUROG3</italic>, encoding neurogenin-3, a basic helix loop helix transcription factor essential in the development of enteroendocrine, Paneth, goblet, and enterocyte cells in the intestine and pancreatic endocrine cells [<xref ref-type="bibr" rid="dmn.REF.pinney.2011.1960">Pinney et al 2011</xref>]. Diabetes may also present later in childhood [<xref ref-type="bibr" rid="dmn.REF.wang.2006.270">Wang et al 2006</xref>]. Pancreatic exocrine function may also be affected. Inheritance is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><bold>A syndrome of neonatal diabetes mellitus and renal abnormalities</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/137920">137920</ext-link>) has been associated with pathogenic variants in <italic toggle="yes">HNF1B</italic>. HNF1 beta is a key regulator of a transcriptional network that controls the specification, growth and differentiation of the embryonic pancreas. The diabetes phenotype in individuals heterozygous for a single pathogenic variant in <italic toggle="yes">HNF1B</italic> manifests more frequently later in life (renal cysts and diabetes syndrome &#x02013; RCAD, or MODY 5). The neonatal presentation due to biallelic pathogenic variants in <italic toggle="yes">HNF1B</italic> is characterized by evidence of severe insulin deficiency (low birth weight, diabetes ketoacidosis) and pancreatic exocrine insufficiency due to hypoplastic pancreas. Other manifestations include genital tract malformations, hyperuricemia and gout, as well as abnormal liver function. The inheritance is autosomal recessive but penetrance is incomplete [<xref ref-type="bibr" rid="dmn.REF.yorifuji.2004.2905">Yorifuji et al 2004</xref>, <xref ref-type="bibr" rid="dmn.REF.edghill.2006.1301">Edghill et al 2006</xref>, <xref ref-type="bibr" rid="dmn.REF.haldorsen.2008.782">Haldorsen et al 2008</xref>, <xref ref-type="bibr" rid="dmn.REF.tjora.2013.946">Tjora et al 2013</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>A</bold>
<bold>syndrome of neonatal diabetes with brain malformations, microcephaly, and microphthalmia</bold> has been associated with pathogenic variants in <italic toggle="yes">PAX6</italic> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/607108">607108</ext-link>). PAX6 is a transcription factor involved in eye and brain development that also plays a role in pituitary development and in &#x000df;-cell differentiation and function. In heterozygous individuals, diabetes presents later in life, however in individuals with biallelic pathogenic variants, the diabetes manifests in the neonatal period. The central nervous system (CNS) phenotype includes microcephaly and panhypopituitarism. The ocular phenotype includes aniridia, keratopathy, optic nerve defects, cataracts, microphthalmia and anophthalmia [<xref ref-type="bibr" rid="dmn.REF.yasuda.2002.224">Yasuda et al 2002</xref>, <xref ref-type="bibr" rid="dmn.REF.solomon.2009.2543">Solomon et al 2009</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Wolfram syndrome &#x02013; diabetes mellitus with optic atrophy, diabetes insipidus, and/or deafness.</bold> The associated gene, <italic toggle="yes">WFS1</italic>, encodes an endoplasmic reticulum (ER) membrane-embedded protein involved in regulating ER stress. The earliest and most consistent phenotypic characteristic in individuals with Wolfram syndrome is diabetes, which is usually diagnosed during childhood, but it can also present in the first year of life. The inheritance is autosomal recessive [<xref ref-type="bibr" rid="dmn.REF.rigoli.2011.103">Rigoli et al 2011</xref>, <xref ref-type="bibr" rid="dmn.REF.rohayem.2011.1503">Rohayem et al 2011</xref>]. See <related-object link-type="booklink" source-id="gene" document-id="wfs" document-type="chapter"><italic toggle="yes">WFS1</italic>-Related Disorders</related-object>.</p>
          </list-item>
          <list-item>
            <p><bold>A syndrome of neonatal diabetes mellitus, deafness, and thiamine-responsive megaloblastic anemia</bold> caused by pathogenic variants in <italic toggle="yes">SLC19A2</italic>. <italic toggle="yes">SLC19A2</italic> encodes a thiamine transporter. Also known as Rogers syndrome, this syndrome can also be associated with neurologic deficits, visual disturbances, and cardiac abnormalities. The diabetes phenotype can manifests in the first six months of life or later. The inheritance is autosomal recessive [<xref ref-type="bibr" rid="dmn.REF.shawsmith.2012.314">Shaw-Smith et al 2012</xref>]. See <related-object link-type="booklink" source-id="gene" document-id="trma" document-type="chapter">Thiamine-Responsive Megaloblastic Anemia Syndrome</related-object>.</p>
          </list-item>
          <list-item>
            <p><bold>A</bold>
<bold>syndrome of neonatal diabetes mellitus, developmental delays, sacral agenesis and imperforated anus</bold> caused by pathogenic variants in <italic toggle="yes">MNX1</italic>. Other manifestations include intrauterine growth retardation, hypoplastic lungs. Inheritance is autosomal recessive [<xref ref-type="bibr" rid="dmn.REF.flanagan.2014.146">Flanagan et al 2014</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>A syndrome of neonatal diabetes mellitus, developmental delays, hypotonia, short stature and deafness</bold> caused by pathogenic variants in <italic toggle="yes">NKX2-2</italic>. Other manifestations include intrauterine growth retardation, cortical blindness, and impaired visual tracking. Inheritance is autosomal recessive [<xref ref-type="bibr" rid="dmn.REF.flanagan.2014.146">Flanagan et al 2014</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>A syndrome of neonatal diabetes, microcephaly, lissencephaly, and epileptic encephalopathy</bold> caused by pathogenic variants in <italic toggle="yes">IER3IP1</italic>. <italic toggle="yes">IERI31P1</italic> encodes a highly conserved protein with marked expression in beta cells in cerebral cortex but which function is not well known. Inheritance is autosomal recessive [<xref ref-type="bibr" rid="dmn.REF.shalev.2014.252">Shalev et al 2014</xref>].</p>
          </list-item>
        </list>
        <p><bold>Testing strategy for syndromic permanent neonatal diabetes mellitus.</bold> Individuals with PNDM <bold>and</bold>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pancreatic exocrine insufficiency or agenesis and cardiac abnormalities should be tested for pathogenic variants in <italic toggle="yes">GATA4</italic> and <italic toggle="yes">GATA6</italic>;</p>
          </list-item>
          <list-item>
            <p>Enteropathy and dermatitis should be tested for pathogenic variants in <italic toggle="yes">FOXP3</italic> (<related-object link-type="booklink" source-id="gene" document-id="ipex" document-type="chapter">IPEX syndrome</related-object>);</p>
          </list-item>
          <list-item>
            <p>Cerebellar involvement should be tested for pathogenic variants in <italic toggle="yes">PTF1A</italic>;</p>
          </list-item>
          <list-item>
            <p>Congenital hypothyroidism should be tested for pathogenic variants in <italic toggle="yes">GLIS3</italic>;</p>
          </list-item>
          <list-item>
            <p>Cerebellar hypoplasia, sensorineural deafness, and visual impairment should be tested for pathogenic variants in <italic toggle="yes">NEUROD1</italic>;</p>
          </list-item>
          <list-item>
            <p>Pancreatic hypoplasia, intestinal atresia, and gall bladder hypoplasia should be tested for pathogenic variants in <italic toggle="yes">RFX6</italic>;</p>
          </list-item>
          <list-item>
            <p>Congenital malabsorptive diarrhea should be tested for pathogenic variants in <italic toggle="yes">NEUROG3</italic>;</p>
          </list-item>
          <list-item>
            <p>Skeletal abnormalities and liver dysfunction should be tested for pathogenic variants in <italic toggle="yes">EIF2AK3</italic> (WRS - Wolcott-Rallison syndrome);</p>
          </list-item>
          <list-item>
            <p>Megaloblastic anemia and deafness should be tested for pathogenic variants in <italic toggle="yes">SLC19A2</italic> (<related-object link-type="booklink" source-id="gene" document-id="trma" document-type="chapter">TRMA</related-object>; thiamine-responsive megaloblastic anemia);</p>
          </list-item>
          <list-item>
            <p>Renal and genital abnormalities should be tested for pathogenic variants in <italic toggle="yes">HNF1B;</italic></p>
          </list-item>
          <list-item>
            <p>Brain malformations, microcephaly and microphthalmia should be tested for pathogenic variants in <italic toggle="yes">PAX6</italic>;</p>
          </list-item>
          <list-item>
            <p>Optic atrophy, diabetes insipidus and deafness should be tested for pathogenic variants in <italic toggle="yes">WFS1</italic> (<related-object link-type="booklink" source-id="gene" document-id="wfs" document-type="chapter">Wolfram syndrome</related-object>).</p>
          </list-item>
        </list>
      </sec>
      <sec id="dmn.Management">
        <title>Management</title>
        <sec id="dmn.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with neonatal diabetes mellitus as a result of pathogenic variants in <italic toggle="yes">ABCC8</italic> or <italic toggle="yes">KCNJ11</italic>, a complete neurologic evaluation should be performed.</p>
          <p>To establish the extent of disease in an individual with suspected or confirmed pathogenic variants in <italic toggle="yes">PDX1</italic>, imaging of the pancreas and evaluation of pancreatic exocrine function (stool elastase, serum concentrations of fat-soluble vitamins) should be performed.</p>
          <p>Consultation with a clinical geneticist and/or genetic counselor should be obtained early in the evaluation of PNDM.</p>
        </sec>
        <sec id="dmn.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Initial treatment.</bold> Rehydration and intravenous insulin infusion should be started promptly after diagnosis, particularly in infants with ketoacidosis.</p>
          <p><bold>Long-term medical management.</bold> An appropriate regimen of subcutaneous insulin administration should be established when the infant is stable and tolerating oral feedings. Few data on the most appropriate insulin preparations for young infants are available.</p>
          <list list-type="bullet">
            <list-item>
              <p>Intermediate-acting insulin preparations (neutral protamine Hagedorn [NPH]) tend to have a shorter duration of action in infants, possibly because of smaller dose size or higher subcutaneous blood flow.</p>
            </list-item>
            <list-item>
              <p>The longer-acting preparations with no significant peak-of-action effect such as Lantus<sup>&#x000ae;</sup> (glargine) or Levemir<sup>&#x000ae;</sup> (detemir) may work better in small infants.</p>
            </list-item>
            <list-item>
              <p>In individuals with very low insulin requirements, diluted insulin (5 or 10 U/mL) may be more appropriate if used with caution.</p>
            </list-item>
            <list-item>
              <p>Some centers recommend the use of continuous subcutaneous insulin infusion for young infants [<xref ref-type="bibr" rid="dmn.REF.polak.2007.12">Polak &#x00026; Cave 2007</xref>] as a safer, more physiologic, and more accurate way of administering insulin.</p>
            </list-item>
            <list-item>
              <p>Caution:</p>
              <list list-type="bullet">
                <list-item>
                  <p>In general, rapid-acting (lispro and aspart) and short-acting (regular) preparations (except when used as a continuous intravenous or subcutaneous infusion) should be avoided as they may cause severe hypoglycemic events.</p>
                </list-item>
                <list-item>
                  <p>Extreme caution should be observed when using a diluted insulin preparation in order to avoid dose errors.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>Identification of a <italic toggle="yes">KCNJ11</italic> or <italic toggle="yes">ABCC8</italic> pathogenic variant is important for clinical management since most individuals with these pathogenic variants can be treated with oral sulfonylureas. Children with pathogenic variants in <italic toggle="yes">KCNJ11</italic> or <italic toggle="yes">ABCC8</italic> can be transitioned to therapy with oral sulfonylureas; high doses are usually required (0.4-1.0 mg/kg/day of glibenclamide). Transfer protocols are available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.diabetesgenes.org">www.diabetesgenes.org</ext-link>. Treatment with sulfonylureas is associated with improved glycemic control [<xref ref-type="bibr" rid="dmn.REF.hattersley.2005.2503">Hattersley &#x00026; Ashcroft 2005</xref>, <xref ref-type="bibr" rid="dmn.REF.pearson.2006.467">Pearson et al 2006</xref>, <xref ref-type="bibr" rid="dmn.REF.thurber.2015.1430">Thurber et al 2015</xref>, <xref ref-type="bibr" rid="dmn.REF.babiker.2016.1162">Babiker et al 2016</xref>].</p>
          <p>Long-term insulin therapy is required for all other causes of PNDM, although mild beneficial effect of oral sulfonylureas in persons with <italic toggle="yes">GCK</italic> pathogenic variants has been reported [<xref ref-type="bibr" rid="dmn.REF.turkkahraman.2008.122">Turkkahraman et al 2008</xref>, <xref ref-type="bibr" rid="dmn.REF.hussain.2010.179">Hussain 2010</xref>].</p>
          <p>High caloric intake should be maintained to achieve weight gain.</p>
          <p>Pancreatic enzyme replacement therapy is required in persons with exocrine pancreatic insufficiency.</p>
        </sec>
        <sec id="dmn.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Aggressive treatment and frequent monitoring of blood glucose concentrations is essential to avoid acute complications such as diabetic ketoacidosis and hypoglycemia.</p>
          <p>Long-term complications of diabetes mellitus can be significantly reduced by maintaining blood glucose concentrations in the appropriate range. The American Diabetes Association recommends the following glycemic goals across all pediatric age-groups [<xref ref-type="bibr" rid="dmn.REF.american_diabetes_association.2016a.s86">American Diabetes Association 2016a</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Glycemic targets for children younger than age six years:</p>
              <list list-type="bullet">
                <list-item>
                  <p>90-130 mg/dL before meals</p>
                </list-item>
                <list-item>
                  <p>90-150 mg/dL at bedtime/overnight</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Hemoglobin A1c value &#x0003c; 7.5%</p>
            </list-item>
          </list>
        </sec>
        <sec id="dmn.Surveillance">
          <title>Surveillance</title>
          <p>Lifelong monitoring (&#x02265;4x/day) of blood glucose concentrations is indicated to achieve the goals of therapy.</p>
          <p>Children with PNDM, particularly those with a pathogenic variant in <italic toggle="yes">KCNJ11</italic> or <italic toggle="yes">ABCC8</italic>, should undergo periodic developmental evaluations.</p>
          <p>Yearly screening for chronic complications associated with diabetes mellitus should be started after age ten years and should include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Urinalysis for microalbuminuria</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic examination to screen for retinopathy</p>
            </list-item>
          </list>
        </sec>
        <sec id="dmn.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>In general, rapid-acting insulin preparations (lispro and aspart) as well as short-acting (regular) insulin preparations should be avoided (except when used as a continuous intravenous or subcutaneous infusion) as they may cause severe hypoglycemic events in young children.</p>
        </sec>
        <sec id="dmn.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="dmn.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="dmn.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>The management of pregnant women with PNDM should conform to the guidelines for treatment of other forms of diabetes during gestation [<xref ref-type="bibr" rid="dmn.REF.american_diabetes_association.2016b.s99">American Diabetes Association 2016b</xref>]. Glycemic control during gestation is not only important to prevent complications in the mother, but also to prevent fetal overgrowth (due to fetal hyperinsulinemia triggered by the excess of maternal glucose crossing the placenta) and associated complications. Referral to a maternal-fetal medicine specialist should be considered. In addition, high resolution ultrasonography and fetal echocardiography should be offered during pregnancy to screen for congenital anomalies in the fetus.</p>
          <p>Until recently, insulin was the mainstay of therapy of diabetes during pregnancy; however, emerging data support the safety and efficacy of glyburide in the treatment of diabetes during pregnancy [<xref ref-type="bibr" rid="dmn.REF.moretti.2008.483">Moretti et al 2008</xref>]. Thus, in women with PNDM treated with glyburide before pregnancy, it is reasonable to continue this treatment if appropriate glycemic control can be achieved.</p>
        </sec>
        <sec id="dmn.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="dmn.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="dmn.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>The mode of inheritance of permanent neonatal diabetes mellitus (PNDM) varies by gene:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold><italic toggle="yes">ABCC8</italic></bold> and <bold><italic toggle="yes">INS</italic>.</bold> Autosomal dominant or autosomal recessive</p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">GCK</italic></bold> and <bold><italic toggle="yes">PDX1</italic>.</bold> Autosomal recessive</p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">KCNJ11.</italic></bold> Autosomal dominant</p>
            </list-item>
          </list>
        </sec>
        <sec id="dmn.Risk_to_Family_Members__Autosomal_Do">
          <title>Risk to Family Members &#x02014; Autosomal Dominant Inheritance</title>
          <table-wrap id="dmn.T.autosomal_dominant_pndm__risk_to_p" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Autosomal Dominant PNDM &#x02013; Risk to Parents of a Proband by Gene</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_dmn.T.autosomal_dominant_pndm__risk_to_p_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                  <th id="hd_h_dmn.T.autosomal_dominant_pndm__risk_to_p_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Percent of Probands with an Affected Parent</th>
                  <th id="hd_h_dmn.T.autosomal_dominant_pndm__risk_to_p_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Percent of Probands with a <italic toggle="yes">De Novo</italic> Pathogenic Variant</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_dmn.T.autosomal_dominant_pndm__risk_to_p_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ABCC8</italic>
                  </td>
                  <td headers="hd_h_dmn.T.autosomal_dominant_pndm__risk_to_p_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">~10%&#x000a0;<sup>1</sup></td>
                  <td headers="hd_h_dmn.T.autosomal_dominant_pndm__risk_to_p_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Most reported cases&#x000a0;<sup>2</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_dmn.T.autosomal_dominant_pndm__risk_to_p_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">INS</italic>
                  </td>
                  <td headers="hd_h_dmn.T.autosomal_dominant_pndm__risk_to_p_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">27%</td>
                  <td headers="hd_h_dmn.T.autosomal_dominant_pndm__risk_to_p_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">73%</td>
                </tr>
                <tr>
                  <td headers="hd_h_dmn.T.autosomal_dominant_pndm__risk_to_p_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">KCNJ11</italic>
                  </td>
                  <td headers="hd_h_dmn.T.autosomal_dominant_pndm__risk_to_p_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">~10%</td>
                  <td headers="hd_h_dmn.T.autosomal_dominant_pndm__risk_to_p_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">90%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="dmn.TF.2.1">
                <label>1. </label>
                <p>A parent may have type 2 diabetes despite having the same <italic toggle="yes">ABCC8</italic> pathogenic variant as their child with neonatal diabetes mellitus [<xref ref-type="bibr" rid="dmn.REF.babenko.2006.456">Babenko et al 2006</xref>].</p>
              </fn>
              <fn id="dmn.TF.2.2">
                <label>2. </label>
                <p>
                  <xref ref-type="bibr" rid="dmn.REF.patch.2007.28">Patch et al [2007]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Parents of a proband</bold> (see <xref ref-type="table" rid="dmn.T.autosomal_dominant_pndm__risk_to_p">Table 2</xref>)</p>
          <list list-type="bullet">
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant in <italic toggle="yes">ABCC8</italic>, <italic toggle="yes">INS</italic>, or <italic toggle="yes">KCNJ11</italic> include molecular genetic testing and clinical testing for diabetes mellitus (oral glucose tolerance testing).</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, possible explanations include a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or germline mosaicism in a parent. Germline mosaicism for a pathogenic variant in <italic toggle="yes">KCNJ11</italic> has been reported [<xref ref-type="bibr" rid="dmn.REF.gloyn.2004a.3932">Gloyn et al 2004a</xref>, <xref ref-type="bibr" rid="dmn.REF.edghill.2007.1773">Edghill et al 2007</xref>]; the overall incidence of germline mosaicism is unknown.</p>
            </list-item>
            <list-item>
              <p>Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of failure by health care professionals to recognize the syndrome and/or a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p>
          <list list-type="bullet">
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">ABCC8</italic>, <italic toggle="yes">INS</italic>, or <italic toggle="yes">KCNJ11</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the possibility of parental germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with PNDM inherited in an autosomal dominant manner has a 50% chance of inheriting the <italic toggle="yes">ABCC8</italic>, <italic toggle="yes">INS</italic>, or <italic toggle="yes">KCNJ11</italic> pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents: if a parent is affected, his or her family members may be at risk.</p>
        </sec>
        <sec id="dmn.Risk_to_Family_Members__Autosomal_Re">
          <title>Risk to Family Members &#x02014; Autosomal Recessive Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of a child with autosomal recessive PNDM are obligate heterozygotes and therefore have one PNDM-related pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>The parents of a child with autosomal recessive PNDM may or may not be affected (see <xref ref-type="sec" rid="dmn.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>).</p>
              <list list-type="bullet">
                <list-item>
                  <p><bold><italic toggle="yes">ABCC8</italic>.</bold> In 43% of affected individuals, <italic toggle="yes">ABCC8</italic>-related PNDM is inherited in an autosomal recessive manner from unaffected parents with heterozygous pathogenic variants [<xref ref-type="bibr" rid="dmn.REF.patch.2007.28">Patch et al 2007</xref>].</p>
                </list-item>
                <list-item>
                  <p><bold><italic toggle="yes">INS</italic></bold>-related PNDM has also been reported to be inherited in an autosomal recessive manner from unaffected parents [<xref ref-type="bibr" rid="dmn.REF.garin.2010.3105">Garin et al 2010</xref>]. Heterozygotes for pathogenic variants in <italic toggle="yes">INS</italic> associated with recessively inherited NDM may have adult onset diabetes [<xref ref-type="bibr" rid="dmn.REF.raile.2011.255">Raile et al 2011</xref>].</p>
                </list-item>
                <list-item>
                  <p><bold><italic toggle="yes">GCK</italic> and <italic toggle="yes">PDX1</italic>.</bold> Heterozygotes for pathogenic variants in <italic toggle="yes">GCK</italic> and <italic toggle="yes">PDX1</italic> have milder forms of diabetes mellitus (<italic toggle="yes">GCK</italic>-familial monogenic diabetes and <italic toggle="yes">PDX1</italic>-familial monogenic diabetes, respectively).</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being heterozygous, and a 25% chance of being unaffected and not heterozygous.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes for pathogenic variants in <italic toggle="yes">GCK</italic>, <italic toggle="yes">INS</italic>, or <italic toggle="yes">PDX1</italic> have a milder form of diabetes mellitus (e.g., <italic toggle="yes">GCK</italic>-familial monogenic diabetes, previously known as MODY2, or <italic toggle="yes">PDX1</italic>-familial monogenic diabetes, previously known as MODY4). Heterozygotes for pathogenic variants in <italic toggle="yes">ABCC8</italic> have normal glucose tolerance.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with autosomal recessive neonatal diabetes mellitus are obligate heterozygotes for a pathogenic variant.</p>
          <p><bold>Other family members.</bold> Each sib of the proband's parents is at a 50% risk of being heterozygous for a PNDM-related pathogenic variant.</p>
        </sec>
        <sec id="dmn.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the PNDM-related pathogenic variants in the family.</p>
        </sec>
        <sec id="dmn.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="dmn.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the PNDM-related pathogenic variant(s) have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for PNDM are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="dmn.Resources">
        <title>Resources</title>
      </sec>
      <sec id="dmn.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p>
          <bold>
            <italic toggle="yes">ABCC8</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">ABCC8</italic> is located 4.5 kb centromeric to <italic toggle="yes">KCNJ11</italic> on chromosome 11p15.1. The gene spans approximately 84 kb of genomic DNA and is made up of 39 exons. The shorter transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000352.4">NM_000352.4</ext-link> is 4935 bp. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="dmn" object-id="dmn.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> More than 25 different <italic toggle="yes">ABCC8</italic> variants have been associated with permanent neonatal diabetes (see <xref ref-type="table" rid="dmn.T.selected_abcc8_pathogenic_variants">Table 3</xref>). In addition, several other variants in compound heterozygotes have been associated with PNDM. (See <xref ref-type="bibr" rid="dmn.REF.flanagan.2009.170">Flanagan et al [2009]</xref> for variants in <italic toggle="yes">ABCC8</italic> that cause both neonatal diabetes mellitus and persistent hyperinsulinemic hypoglycemia of infancy.)</p>
        <table-wrap id="dmn.T.selected_abcc8_pathogenic_variants" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p>Selected <italic toggle="yes">ABCC8</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">References</th>
                <th id="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.215A&#x0003e;G</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn72Ser</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <xref ref-type="bibr" rid="dmn.REF.ellard.2007.375">Ellard et al [2007]</xref>
                </td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_4" rowspan="13" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=118582254">NM_000352.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=118582255">NP_000343.2</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.257T&#x0003e;C</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val86Ala</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <xref ref-type="bibr" rid="dmn.REF.ellard.2007.375">Ellard et al [2007]</xref>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.257T&#x0003e;G</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val86Gly</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <xref ref-type="bibr" rid="dmn.REF.ellard.2007.375">Ellard et al [2007]</xref>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.394T&#x0003e;G</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe132Val</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <xref ref-type="bibr" rid="dmn.REF.ellard.2007.375">Ellard et al [2007]</xref>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.394T&#x0003e;C</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe132Leu</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <xref ref-type="bibr" rid="dmn.REF.proks.2006.1793">Proks et al [2006]</xref>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.404T&#x0003e;C</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu135Pro</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <xref ref-type="bibr" rid="dmn.REF.ellard.2007.375">Ellard et al [2007]</xref>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.627C&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp209Glu</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="dmn.REF.ellard.2007.375">Ellard et al [2007]</xref>,<break/><xref ref-type="bibr" rid="dmn.REF.flanagan.2007.1930">Flanagan et al [2007]</xref></td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.631C&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln211Lys</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <xref ref-type="bibr" rid="dmn.REF.ellard.2007.375">Ellard et al [2007]</xref>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.638T&#x0003e;G</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu213Arg</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                  <xref ref-type="bibr" rid="dmn.REF.babenko.2006.456">Babenko et al [2006]</xref>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.674T&#x0003e;C</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu225Phe</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1144G&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu382Lys</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <xref ref-type="bibr" rid="dmn.REF.ellard.2007.375">Ellard et al [2007]</xref>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3554C&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala1185Glu</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <xref ref-type="bibr" rid="dmn.REF.ellard.2007.375">Ellard et al [2007]</xref>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4270A&#x0003e;G</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ile1424Val</td>
                <td headers="hd_h_dmn.T.selected_abcc8_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="dmn.REF.babenko.2006.456">Babenko et al [2006]</xref>,<break/><xref ref-type="bibr" rid="dmn.REF.masia.2007a.1357">Masia et al [2007a]</xref></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>For more information see <xref ref-type="bibr" rid="dmn.REF.patch.2007.28">Patch et al [2007]</xref>, Figure 2 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://onlinelibrary.wiley.com/doi/10.1111/j.1463-1326.2007.00772.x/pdf">full text</ext-link>) and <xref ref-type="bibr" rid="dmn.REF.edghill.2010.193">Edghill et al [2010]</xref>, Figures 2 and 3 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://link.springer.com/article/10.1007%2Fs11154-010-9149-x/fulltext.html">full text</ext-link>).</p>
        <p><bold>Normal gene product.</bold> The transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000352.4">NM_000352.4</ext-link> encodes ATP-binding cassette sub-family C member 8 protein (SUR1) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000343.2">NP_000343.2</ext-link>), which has 1581 amino acids. See <bold><italic toggle="yes">KCNJ11</italic></bold>, <bold>Normal gene product</bold>.</p>
        <p><bold>Abnormal gene product.</bold> Pathogenic variants in <italic toggle="yes">ABCC8</italic> result in nonfunctional or dysfunctional K<sub>ATP</sub> channels. The increased activity of K<sub>ATP</sub> channels resulting from pathogenic variants in <italic toggle="yes">ABCC8</italic> is caused by an increase in the magnesium-dependent stimulatory action of SUR1 on the pore [<xref ref-type="bibr" rid="dmn.REF.babenko.2006.456">Babenko et al 2006</xref>, <xref ref-type="bibr" rid="dmn.REF.masia.2007a.1357">Masia et al 2007a</xref>], or by alteration in the inhibitory action of ATP on a mutant SUR1 channel [<xref ref-type="bibr" rid="dmn.REF.proks.2006.1793">Proks et al 2006</xref>].</p>
        <p>
          <bold>
            <italic toggle="yes">GCK</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">GCK</italic> spans more than 45 kb of genomic DNA; the transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000162.3">NM_000162.3</ext-link>, which encodes the isoform expressed specifically in pancreatic islet beta cells, has ten exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="dmn" object-id="dmn.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> At least ten variants of <italic toggle="yes">GCK</italic> have been reported in association with PNDM (see <xref ref-type="table" rid="dmn.T.selected_gck_pathogenic_variants">Table 4</xref>). These are nonsense, missense, or frameshift variants.</p>
        <table-wrap id="dmn.T.selected_gck_pathogenic_variants" orientation="portrait" position="anchor">
          <label>Table 4. </label>
          <caption>
            <p>Selected <italic toggle="yes">GCK</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                <th id="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">References</th>
                <th id="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.629T&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Met210Leu</td>
                <td headers="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                  <xref ref-type="bibr" rid="dmn.REF.nj_lstad.2001.1588">Nj&#x000f8;lstad et al [2001]</xref>
                </td>
                <td headers="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_4" rowspan="6" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000162">NM_000162.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=4503951">NP_000153.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.683C&#x0003e;T</td>
                <td headers="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr228Met</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.790G&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly264Ser</td>
                <td headers="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                  <xref ref-type="bibr" rid="dmn.REF.nj_lstad.2003.2854">Nj&#x000f8;lstad et al [2003]</xref>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">1133C&#x0003e;T</td>
                <td headers="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala378Val</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1190G&#x0003e;T</td>
                <td headers="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg397Leu</td>
                <td headers="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <xref ref-type="bibr" rid="dmn.REF.porter.2005.131">Porter et al [2005]</xref>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1505+2T&#x0003e;G<break/>(IVS8+2T&#x0003e;G)</td>
                <td headers="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                <td headers="hd_h_dmn.T.selected_gck_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <xref ref-type="bibr" rid="dmn.REF.nj_lstad.2003.2854">Nj&#x000f8;lstad et al [2003]</xref>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn>
              <p>NA= not applicable</p>
            </fn>
            <fn id="dmn.TF.4.1">
              <label>1. </label>
              <p>Variant designation that does not conform to current naming conventions</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The isoform <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000153.1">NP_000153.1</ext-link>, expressed specifically in pancreatic islet beta cells, has 465 amino acid residues. Glucokinase is a hexokinase that serves as the glucose sensor in pancreatic beta cells and appears to have a similar role in enteroendocrine cells, hepatocytes, and hypothalamic neurons. In beta cells, glucokinase controls the rate-limiting step of glucose metabolism and is responsible for glucose-stimulated insulin secretion [<xref ref-type="bibr" rid="dmn.REF.matschinsky.2002.s394">Matschinsky 2002</xref>].</p>
        <p><bold>Abnormal gene product.</bold> The reported pathogenic missense variants alter the kinetics of the enzyme: the glucose S<sub>0.5</sub> is raised and the ATP K<sub>m</sub> is increased. The overall result for inactivating pathogenic variants is a decrease in the phosphorylating potential of the enzyme, which extrapolates to a marked reduction in beta-cell glucose usage and hyperglycemia. Splice site pathogenic variants are predicted to lead to the synthesis of an inactive protein.</p>
        <p>
          <bold>
            <italic toggle="yes">INS</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold> The <italic toggle="yes">INS</italic> transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=109148525">NM_000207.2</ext-link> has three exons. Exon 2 encodes the signal peptide, the B chain, and part of the C peptide; exon 3 encodes the reminder of the C peptide and the A chain. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="dmn" object-id="dmn.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> More than 25 variants have been described in association with PNDM [<xref ref-type="bibr" rid="dmn.REF.st_y.2007.15040">St&#x000f8;y et al 2007</xref>, <xref ref-type="bibr" rid="dmn.REF.polak.2008.1115">Polak et al 2008</xref>, <xref ref-type="bibr" rid="dmn.REF.st_y.2010.205">St&#x000f8;y et al 2010</xref>]. See <xref ref-type="table" rid="dmn.T.selected_ins_pathogenic_variants">Table 5</xref> and <xref ref-type="sec" rid="dmn.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>.</p>
        <p>See <xref ref-type="bibr" rid="dmn.REF.st_y.2010.205">St&#x000f8;y et al [2010]</xref> for variants in <italic toggle="yes">INS</italic> that cause diabetes mellitus.</p>
        <table-wrap id="dmn.T.selected_ins_pathogenic_variants" orientation="portrait" position="anchor">
          <label>Table 5. </label>
          <caption>
            <p>Selected <italic toggle="yes">INS</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change&#x000a0;<sup>1</sup></th>
                <th id="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">References</th>
                <th id="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.-366_343del&#x000a0;<sup>2,&#x000a0;3</sup></td>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_2" rowspan="5" valign="middle" align="left" colspan="1">NA</td>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_3" rowspan="19" valign="middle" align="left" colspan="1"><xref ref-type="bibr" rid="dmn.REF.st_y.2007.15040">St&#x000f8;y et al [2007]</xref>, <xref ref-type="bibr" rid="dmn.REF.polak.2008.1115">Polak et al [2008]</xref>, <xref ref-type="bibr" rid="dmn.REF.st_y.2010.205">St&#x000f8;y et al [2010]</xref></td>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_4" rowspan="19" valign="middle" align="left" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=109148525">NM_000207.2</ext-link>&#x000a0;<sup>4</sup><break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=4557671">NP_000198.1</ext-link></td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">c.-370-?186+?del&#x000a0;<sup>2,&#x000a0;3,&#x000a0;5,&#x000a0;6</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">c.-331C&#x0003e;A&#x000a0;<sup>2,&#x000a0;3,&#x000a0;7,&#x000a0;8</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">c.-331C&#x0003e;G&#x000a0;<sup>2,&#x000a0;3,&#x000a0;4,&#x000a0;9</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">c.-218A&#x0003e;C&#x000a0;<sup>2,&#x000a0;3,&#x000a0;7,&#x000a0;10</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3G&#x0003e;A&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.0?&#x000a0;<sup>11</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3G&#x0003e;T&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.0?&#x000a0;<sup>11</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.71C&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala24Asp</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.94G&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly32Ser</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.94G&#x0003e;C</td>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly32Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.127T&#x0003e;G</td>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys43Gly</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.140G&#x0003e;T</td>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly47Val</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.143T&#x0003e;G</td>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe48Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.184C&#x0003e;T&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln62Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.265C&#x0003e;T</td>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg89Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.268G&#x0003e;T</td>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly90Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.287G&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys96Tyr</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.323A&#x0003e;G</td>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr108Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.*59A&#x0003e;G&#x000a0;<sup>2,&#x000a0;12</sup></td>
                <td headers="hd_h_dmn.T.selected_ins_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn>
              <p>NA = not applicable</p>
            </fn>
            <fn id="dmn.TF.5.1">
              <label>1. </label>
              <p>Negative number indicates the number of base pairs preceding the A of the ATG start codon. An asterisk indicates a position in the 3&#x02019;UTR; the number is the position relative to the first base past the stop codon.</p>
            </fn>
            <fn id="dmn.TF.5.2">
              <label>2. </label>
              <p>A 646-bp deletion. See <xref ref-type="table" rid="dmn.T.molecular_genetic_testing_used_in">Table 1</xref> (footnote 10) and <xref ref-type="sec" rid="dmn.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>.</p>
            </fn>
            <fn id="dmn.TF.5.3">
              <label>3. </label>
              <p>
                <xref ref-type="bibr" rid="dmn.REF.garin.2010.3105">Garin et al [2010]</xref>
              </p>
            </fn>
            <fn id="dmn.TF.5.4">
              <label>4. </label>
              <p>Reference sequences of the insulin preproprotein (or preproinsulin)</p>
            </fn>
            <fn id="dmn.TF.5.5">
              <label>5. </label>
              <p>Denotes an exon deletion starting at an unknown position in the promoter of coding DNA nucleotide -370 and ending at an unknown position in the intron 3&#x02019; of the coding DNA nucleotide 186 [<xref ref-type="bibr" rid="dmn.REF.st_y.2010.205">St&#x000f8;y et al 2010</xref>]</p>
            </fn>
            <fn id="dmn.TF.5.6">
              <label>6. </label>
              <p>
                <xref ref-type="bibr" rid="dmn.REF.raile.2011.255">Raile et al [2011]</xref>
              </p>
            </fn>
            <fn id="dmn.TF.5.7">
              <label>7. </label>
              <p>
                <xref ref-type="bibr" rid="dmn.REF.bonnefond.2011.28414">Bonnefond et al [2011]</xref>
              </p>
            </fn>
            <fn id="dmn.TF.5.8">
              <label>8. </label>
              <p>-94 relative to transcription initiation site</p>
            </fn>
            <fn id="dmn.TF.5.9">
              <label>9. </label>
              <p>-93 relative to transcription initiation site</p>
            </fn>
            <fn id="dmn.TF.5.10">
              <label>10. </label>
              <p>A+20 relative to transcription initiation site</p>
            </fn>
            <fn id="dmn.TF.5.11">
              <label>11. </label>
              <p>p.0? = effect unknown; probably no protein is produced</p>
            </fn>
            <fn id="dmn.TF.5.12">
              <label>12. </label>
              <p>59 nucleotides 3' of the termination codon (in the 3'UTR)</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The insulin preproprotein <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000198.1">NP_000198.1</ext-link> encoded by transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=109148525">NM_000207.2</ext-link> has 110 amino acids. Insulin is synthesized by the pancreatic beta cells and consists of two dissimilar polypeptide chains, A and B, which are linked by two disulfide bonds. Chains A and B are derived from a 1-chain precursor, proinsulin. Proinsulin is converted to insulin by enzymatic removal of a segment that connects the amino end of the A chain to the carboxyl end of the B chain. This segment is called the C peptide.</p>
        <p><bold>Abnormal gene product.</bold> The diabetes-associated pathogenic variants lead to the synthesis of a structurally abnormal preproinsulin or proinsulin protein. The variants associated with PNDM disrupt proinsulin folding and/or disulfide bond formation. Some reported variants disrupt normal disulfide bonds (p.Cys43Gly and p.Cys96Tyr) or add an additional unpaired cysteine residue (p.Arg89Cys and p.Gly90Cys) at the A-chain C-peptide cleavage site. The variant p.Tyr108Cys may cause mispairing of cysteines in a critical region close to a disulfide bond [<xref ref-type="bibr" rid="dmn.REF.st_y.2007.15040">St&#x000f8;y et al 2007</xref>]. All of the pathogenic variants are likely to act in a dominant manner to disrupt insulin biosynthesis and induce endoplasmic reticulum (ER) stress. The exact mechanism by which these unpaired cysteines disrupt ER function remains unclear [<xref ref-type="bibr" rid="dmn.REF.izumi.2003.409">Izumi et al 2003</xref>]. Three other pathogenic variants (p.Gly32Ser, p.Gly32Arg, and p.Gly47Val) are located in a residue that is invariant in both insulin and the insulin-like growth factors and must play an important structural role. It is believed that these glycine variants also act similarly to impair proinsulin folding and thereby induce ER stress via the unfolded protein response.</p>
        <p>
          <bold>
            <italic toggle="yes">KCNJ11</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">KCNJ11</italic> is located 4.5 kb telomeric to <italic toggle="yes">ABCC8</italic> on chromosome 11p15.1. The gene spans approximately 3.4 kb of genomic DNA and has a single exon. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="dmn" object-id="dmn.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> More than 20 different pathogenic variants in <italic toggle="yes">KCNJ11</italic> have been reported in association with neonatal diabetes mellitus (see <xref ref-type="table" rid="dmn.T.selected_kcnj11_variants">Table 6</xref>). The two common hot spots for recurrent mutation are at amino acid residues Val59 and Arg201 [<xref ref-type="bibr" rid="dmn.REF.hattersley.2005.2503">Hattersley &#x00026; Ashcroft 2005</xref>]. (See <xref ref-type="bibr" rid="dmn.REF.flanagan.2009.170">Flanagan et al [2009]</xref> for variants in <italic toggle="yes">KCNJ11</italic> that cause both neonatal diabetes mellitus and persistent hyperinsulinemic hypoglycemia of infancy.)</p>
        <table-wrap id="dmn.T.selected_kcnj11_variants" orientation="portrait" position="anchor">
          <label>Table 6. </label>
          <caption>
            <p>Selected <italic toggle="yes">KCNJ11</italic> Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Classification</th>
                <th id="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Benign</bold>
                </td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.67G&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Glu23Lys&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_4" rowspan="27" valign="middle" align="left" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=62388887">NM_000525.3</ext-link>
<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=62388888">NP_000516.3</ext-link></td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_1" rowspan="26" valign="middle" align="left" scope="row" colspan="1">
                  <bold>Pathogenic</bold>
                </td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.103T&#x0003e;G</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Phe35Val</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.103T&#x0003e;C</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Phe35Leu</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.124T&#x0003e;C</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Cys42Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.149G&#x0003e;C</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg50Pro</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.155A&#x0003e;G</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gln52Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.157G&#x0003e;C</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly53Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.157G&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly53Ser</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.158G&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly53Asp</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.175G&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Val59Met</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.176T&#x0003e;G</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Val59Gly</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.497G&#x0003e;T</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Cys166Phe</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.497G&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Cys166Tyr</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.499A&#x0003e;C</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ile167Leu</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.509A&#x0003e;G</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Lys170Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.510G&#x0003e;C</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Lys170Asn</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.544A&#x0003e;G</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ile182Val</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.602G&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg201His</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.601C&#x0003e;T</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg201Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.602G&#x0003e;T</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg201Leu</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.755T&#x0003e;C</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Val252Ala</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.886A&#x0003e;C</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ile296Leu</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.886A&#x0003e;G</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ile296Val</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.964G&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Glu322Lys</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.989A&#x0003e;G</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr330Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.997T&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Phe333Ile</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1001G&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_kcnj11_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly334Asp</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="dmn.TF.6.1">
              <label>1. </label>
              <p>Associated with type 2 diabetes mellitus; see <xref ref-type="sec" rid="dmn.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=62388887">NM_000525.3</ext-link> encodes the 390-amino acid isoform known as Kir6.2 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=62388888">NP_000516.3</ext-link>). <italic toggle="yes">KCNJ11</italic> and <italic toggle="yes">ABCC8</italic> encode the proteins ATP-sensitive inward rectifier potassium channel 11 (Kir6.2) and ATP-binding cassette sub-family C member 8 (SUR1), respectively; both are components of the beta-cell K<sub>ATP</sub> channel. The K<sub>ATP</sub> channel is a hetero-octameric complex with four Kir6.2 subunits forming the central pore, coupled to four SUR1 subunits. The K<sub>ATP</sub> channels couple the energy state of the beta cell to membrane potential by sensing changes in intracellular phosphate potential (the ATP/ADP ratio). Following the uptake of glucose and its metabolism by glucokinase, there is an increase in the intracellular ATP/ADP ratio results in closure of the K<sub>ATP</sub> channels, depolarization of the cell membrane, and subsequent opening of voltage-dependent Ca<sup>2+</sup> channels. The resulting increase in cytosolic Ca<sup>2+</sup> concentration triggers insulin release.</p>
        <p><bold>Abnormal gene product.</bold> Pathogenic variants in either <italic toggle="yes">ABCC8</italic> or <italic toggle="yes">KCNJ11</italic> result in nonfunctional or dysfunctional K<sub>ATP</sub> channels. In either case, channels do not close, and thus glucose-stimulated insulin secretion does not happen. All pathogenic variants in <italic toggle="yes">KCNJ11</italic> studied to date produce marked decrease in the ability of ATP to inhibit the K<sub>ATP</sub> channel when expressed in heterologous systems. This reduction in ATP sensitivity means the channel opens more fully at physiologically relevant concentrations of ATP, leading to an increase in the K<sub>ATP</sub> current and hyperpolarization of the beta-cell plasma membrane with subsequent suppression of Ca<sup>2+</sup> influx and insulin secretion [<xref ref-type="bibr" rid="dmn.REF.hattersley.2005.2503">Hattersley &#x00026; Ashcroft 2005</xref>].</p>
        <p>
          <bold>
            <italic toggle="yes">PDX1</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold> The <italic toggle="yes">PDX1</italic> transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000209">NM_000209.3</ext-link> has 2573 bp and comprises two exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="dmn" object-id="dmn.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> At least four <italic toggle="yes">PDX1</italic> variants have been described in association with pancreatic agenesis and PNDM:</p>
        <list list-type="bullet">
          <list-item>
            <p>A homozygous single-nucleotide deletion c.188_189delC in one person [<xref ref-type="bibr" rid="dmn.REF.stoffers.1997b.106">Stoffers et al 1997b</xref>]</p>
          </list-item>
          <list-item>
            <p>A homozygous pathogenic missense variant p.Glu178Gly in the <italic toggle="yes">PDX1</italic> homeodomain associated with neonatal diabetes without exocrine insufficiency in two individuals [<xref ref-type="bibr" rid="dmn.REF.nicolino.2010.733">Nicolino et al 2010</xref>]</p>
          </list-item>
          <list-item>
            <p>Compound heterozygosity for p.Glu164Asp and p.Glu178Lys pathogenic variants within exon 2 of <italic toggle="yes">PDX1</italic> [<xref ref-type="bibr" rid="dmn.REF.schwitzgebel.2003.4398">Schwitzgebel et al 2003</xref>]. See <xref ref-type="table" rid="dmn.T.selected_pdx1_pathogenic_variants">Table 7</xref>.</p>
          </list-item>
        </list>
        <table-wrap id="dmn.T.selected_pdx1_pathogenic_variants" orientation="portrait" position="anchor">
          <label>Table 7. </label>
          <caption>
            <p>Selected <italic toggle="yes">PDX1</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_dmn.T.selected_pdx1_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_dmn.T.selected_pdx1_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_dmn.T.selected_pdx1_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_dmn.T.selected_pdx1_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.188_189delC</td>
                <td headers="hd_h_dmn.T.selected_pdx1_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro63ArgfsTer60</td>
                <td headers="hd_h_dmn.T.selected_pdx1_pathogenic_variants_1_1_1_3" rowspan="4" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000209">NM_000209.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_000200.1">NP_000200.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_pdx1_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.492G&#x0003e;T</td>
                <td headers="hd_h_dmn.T.selected_pdx1_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu164Asp</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_pdx1_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.532G&#x0003e;A</td>
                <td headers="hd_h_dmn.T.selected_pdx1_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu178Lys</td>
              </tr>
              <tr>
                <td headers="hd_h_dmn.T.selected_pdx1_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.533A&#x0003e;G</td>
                <td headers="hd_h_dmn.T.selected_pdx1_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu178Gly</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The pancreas/duodenum homeobox protein 1 or transcription factor insulin promoter factor 1 (PDX1) is a master regulator of pancreatic development and of the differentiation of progenitor cells into the beta-cell phenotype.</p>
        <p>During embryogenesis in the mouse, pdx1 expression initiates on commitment of the foregut endoderm to a pancreatic fate. In the adult organism, pdx1 expression is limited to the beta cell and its importance in maintaining beta-cell phenotype is illustrated by multiple animal models. In mature beta cells, pdx1 regulates the expression of critical genes including insulin, glucokinase, and the glucose transporter <italic toggle="yes">Glut2</italic> [<xref ref-type="bibr" rid="dmn.REF.habener.2005.1025">Habener et al 2005</xref>].</p>
        <p><bold>Abnormal gene product.</bold> The single-nucleotide deletion c.188_189delC predicts the formation of a truncated, inactive protein (p.Pro63ArgfsTer60), whereas the mutated proteins p.Glu164Asp or p.Glu178Lys undergo increased degradation leading to a reduction in protein levels and ultimately to decreased transcriptional activity. The p.Glu178Gly variant reduces PDX1 transactivation.</p>
      </sec>
      <sec id="dmn.References">
        <title>References</title>
        <sec id="dmn.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="dmn.Literature_Cited.reflist0">
            <ref id="dmn.REF.american_diabetes_association.2016a.s86">
              <element-citation publication-type="journal">
                <person-group>
                  <collab>American Diabetes Association</collab>
                </person-group>
                <article-title>Children and adolescents.</article-title>
                <source>Diabetes Care.</source>
                <year>2016a</year>
                <volume>39</volume>
                <supplement>Suppl 1</supplement>
                <fpage>S86</fpage>
                <lpage>S93</lpage>
                <pub-id pub-id-type="pmid">26696687</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.american_diabetes_association.2016b.s99">
              <element-citation publication-type="journal">
                <person-group>
                  <collab>American Diabetes Association</collab>
                </person-group>
                <article-title>Diabetes care in the hospital.</article-title>
                <source>Diabetes Care.</source>
                <year>2016b</year>
                <volume>39</volume>
                <supplement>Suppl 1</supplement>
                <fpage>S99</fpage>
                <lpage>S104</lpage>
                <pub-id pub-id-type="pmid">26696689</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.babenko.2006.456">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Babenko</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cave</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Busiah</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czernichow</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scharfmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bryan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aguilar-Bryan</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaxillaire</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Froguel</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.</article-title>
                <source>N Engl J Med</source>
                <volume>355</volume>
                <fpage>456</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">16885549</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.babiker.2016.1162">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Babiker</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vedovato</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finn</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e4;nnikk&#x000f6;</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakera</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flangan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shepherd</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashcroft</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Successful transfer to sylfonylureas in KCNJ11 is determined by the mutation and duration of diabetes.</article-title>
                <source>Diabetologia</source>
                <volume>59</volume>
                <fpage>1162</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">27033559</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.bonnefond.2011.28414">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bonnefond</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lomberk</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buttar</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Busiah</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaillant</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lobbens</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yengo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dechaume</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mignot</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scharfmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neve</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanyola&#x000e7;</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodoglugil</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pattou</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cav&#x000e9;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iovanna</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaxillaire</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Froguel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urrutia</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Disruption of a novel Kruppel-like transcription factor p300-regulated pathway for insulin biosynthesis revealed by studies of the c.-331 INS mutation found in neonatal diabetes mellitus.</article-title>
                <source>J Biol Chem.</source>
                <year>2011</year>
                <volume>286</volume>
                <fpage>28414</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">21592955</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.colombo.2005.2439">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Colombo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delvecchio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zecchino</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faienza</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavallo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbetti</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Transient neonatal diabetes mellitus is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutation.</article-title>
                <source>Diabetologia</source>
                <volume>48</volume>
                <fpage>2439</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">16205880</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.d_amato.2010.1195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>D&#x02019;Amato</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giacopelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giannattasio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x02019;Annunzio</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bocciardi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Musso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravazzolo</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Genetic investigation in an Italian child with an unusual association of atrial septal defect, attributable to a familial GATA4 gene mutation, and neonatal diabetes due to pancreatic agenesis.</article-title>
                <source>Diabet Med</source>
                <volume>27</volume>
                <fpage>1195</fpage>
                <lpage>200</lpage>
                <pub-id pub-id-type="pmid">20854389</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.de_franco.2013.993">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Franco</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw-Smith</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shepherd</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>International</surname>
                    <given-names>NDM</given-names>
                  </name>
                </person-group>
                <article-title>Consortium, Hattersley AT, Ellard S. GATA6 mutations cause a broad phenotypic spectrum of diabetes from pancreatic agenesis to adult-onset diabetes without exocrine insufficiency.</article-title>
                <source>Diabetes.</source>
                <year>2013</year>
                <volume>62</volume>
                <fpage>993</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23223019</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.dimitri.2011.437">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dimitri</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warner</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minton</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patch</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barr</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hawkes</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wales</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregory</surname>
                    <given-names>JW</given-names>
                  </name>
                </person-group>
                <article-title>Novel GLIS3 mutations demonstrate an extended multisystem phenotype.</article-title>
                <source>Eur J Endocrinol.</source>
                <year>2011</year>
                <volume>164</volume>
                <fpage>437</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">21139041</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.durocher.2006.34">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Durocher</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faure</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labrie</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelletier</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouchard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laframboise</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A novel mutation in the EIF2AK3 gene with variable expressivity in two patients with Wolcott-Rallison syndrome.</article-title>
                <source>Clin Genet</source>
                <volume>70</volume>
                <fpage>34</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16813601</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.edghill.2006.1301">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bingham</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slingerland</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minton</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noordam</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Hepatocyte nuclear factor-1beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1beta in human pancreatic development.</article-title>
                <source>Diabet Med</source>
                <volume>23</volume>
                <fpage>1301</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17116179</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.edghill.2010.193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11.</article-title>
                <source>Rev Endocr Metab Disord</source>
                <volume>11</volume>
                <fpage>193</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20922570</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.edghill.2008.1034">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patch</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boustred</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parrish</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shields</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shepherd</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hussain</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kapoor</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malecki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St&#x000f8;y</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steiner</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philipson</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>GI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <collab>Neonatal Diabetes International Collaborative Group</collab>
                </person-group>
                <article-title>Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood.</article-title>
                <source>Diabetes.</source>
                <year>2008</year>
                <volume>57</volume>
                <fpage>1034</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">18162506</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.edghill.2007.1773">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goriely</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harries</surname>
                    <given-names>LW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rankin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Origin of de novo KCNJ11 mutations and risk of neonatal diabetes for subsequent siblings.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>92</volume>
                <fpage>1773</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17327377</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.ellard.2007.375">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girard</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patch</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harries</surname>
                    <given-names>LW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parrish</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proks</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimomura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haberland</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carson</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashcroft</surname>
                    <given-names>FM</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects.</article-title>
                <source>Am J Hum Genet</source>
                <volume>81</volume>
                <fpage>375</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">17668386</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.flanagan.2009.170">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clauin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellann&#x000e9;-Chantelot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harries</surname>
                    <given-names>LW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism.</article-title>
                <source>Hum Mutat</source>
                <volume>30</volume>
                <fpage>170</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">18767144</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.flanagan.2014.146">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Franco</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lango Allen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerah</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdul-Rasoul</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edge</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alamiri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hussain</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubio-Cabezas</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houghton</surname>
                    <given-names>JAL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patch</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <article-title>Analysis of transcription factors key for mouse pancreatic development establishes NKX2-2 and MNX1 mutations as causes of neonatal diabetes in man.</article-title>
                <source>Cell Metab</source>
                <year>2014</year>
                <volume>19</volume>
                <fpage>146</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">24411943</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.flanagan.2006.1190">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.</article-title>
                <source>Diabetologia</source>
                <volume>49</volume>
                <fpage>1190</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16609879</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.flanagan.2007.1930">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patch</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Mutations in ATP-&#x000e9;sitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood.</article-title>
                <source>Diabetes</source>
                <volume>56</volume>
                <fpage>1930</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17446535</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.florez.2004.1360">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Florez</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burtt</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Bakker</surname>
                    <given-names>PI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Almgren</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuomi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmkvist</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaudet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudson</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaffner</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirschhorn</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groop</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altshuler</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region.</article-title>
                <source>Diabetes</source>
                <volume>53</volume>
                <fpage>1360</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15111507</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.garin.2010.3105">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garin</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akerman</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubio-Cabezas</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rica</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Locke</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maestro</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alshaikh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bundak</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>del Castillo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deeb</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deiss</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Godbole</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hussain</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Connell</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klupa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolouskova</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohsin</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perlman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sumnik</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rial</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ugarte</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasanthi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnstone</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casta&#x000f1;o</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patch</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fern&#x000e1;ndez-Rebollo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raile</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harries</surname>
                    <given-names>LW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casta&#x000f1;o</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez de Nanclares</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <collab>Neonatal Diabetes International Group</collab>
                </person-group>
                <article-title>Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2010</year>
                <volume>107</volume>
                <fpage>3105</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">20133622</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.girard.2006.323">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Girard</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimomura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proks</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Absalom</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez de Nanclares</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashcroft</surname>
                    <given-names>FM</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.</article-title>
                <source>Pflugers Arch</source>
                <volume>453</volume>
                <fpage>323</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">17021801</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.gloyn.2004a.3932">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cummings</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harries</surname>
                    <given-names>LW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004a</year>
                <article-title>Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>89</volume>
                <fpage>3932</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15292329</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.gloyn.2006.824">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diatloff-Zito</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellanne-Chantelot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nivot</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coutant</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robert</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>14</volume>
                <fpage>824</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">16670688</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.gloyn.2001.206">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashim</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashcroft</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashfield</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiltshire</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>RC</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53).</article-title>
                <source>Diabet Med</source>
                <volume>18</volume>
                <fpage>206</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">11318841</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.gloyn.2004b.1838">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearson</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antcliff</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proks</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruining</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slingerland</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howard</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srinivasan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silva</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molnes</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frayling</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sumnik</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Rhijn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wales</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aisenberg</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Njolstad</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashcroft</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <year>2004b</year>
                <article-title>Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.</article-title>
                <source>N Engl J Med</source>
                <volume>350</volume>
                <fpage>1838</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">15115830</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.gloyn.2005.925">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reimann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proks</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearson</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freedenberg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noyes</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashcroft</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gribble</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Relapsing diabetes can result from moderately activating mutations in KCNJ11.</article-title>
                <source>Hum Mol Genet</source>
                <volume>14</volume>
                <fpage>925</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">15718250</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.gloyn.2003.568">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weedon</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owen</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knight</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hitman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sampson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halford</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCarthy</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frayling</surname>
                    <given-names>TM</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes.</article-title>
                <source>Diabetes</source>
                <volume>52</volume>
                <fpage>568</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">12540637</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.greeley.2011.519">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Greeley</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naylor</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philipson</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>GI</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment.</article-title>
                <source>Curr Diab Rep</source>
                <volume>11</volume>
                <fpage>519</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">21993633</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.greeley.2010.464">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Greeley</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucker</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naylor</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>GI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philipson</surname>
                    <given-names>LH</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Neonatal diabetes mellitus: a model for personalized medicine.</article-title>
                <source>Trends Endocrinol Metab</source>
                <volume>21</volume>
                <fpage>464</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">20434356</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.habener.2005.1025">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Habener</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kemp</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>MK</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Minireview: transcriptional regulation in pancreatic development.</article-title>
                <source>Endocrinology</source>
                <volume>146</volume>
                <fpage>1025</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">15604203</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.haldorsen.2008.782">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haldorsen</surname>
                    <given-names>IS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vesterhus</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raeder</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000f8;vik</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molven</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nj&#x000f8;lstad</surname>
                    <given-names>PR</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Lack of pancreatic body and tail in HNF1B mutation carriers.</article-title>
                <source>Diabet Med</source>
                <volume>25</volume>
                <fpage>782</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18644064</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.hani.1998.1511">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hani</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boutin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durand</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Permutt</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velho</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Froguel</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians.</article-title>
                <source>Diabetologia</source>
                <volume>41</volume>
                <fpage>1511</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9867219</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.hansen.2001.1330">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ambye</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grarup</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Echwald</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedersen</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Genetic variability of the SUR1 promoter in relation to beta-cell function and Type II diabetes mellitus.</article-title>
                <source>Diabetologia</source>
                <volume>44</volume>
                <fpage>1330</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11692183</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.hart.2002.3135">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Haeften</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dekker</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bot</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heine</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maassen</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Variations in insulin secretion in carriers of the E23K variant in the KIR6.2 subunit of the ATP-sensitive K(+) channel in the beta-cell.</article-title>
                <source>Diabetes.</source>
                <year>2002</year>
                <volume>51</volume>
                <fpage>3135</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12351459</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.hattersley.2006.352">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruining</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Njolstad</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donaghue</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>ISPAD Clinical Practice Consensus Guidelines 2006-2007. The diagnosis and management of monogenic diabetes in children.</article-title>
                <source>Pediatr Diabetes</source>
                <volume>7</volume>
                <fpage>352</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">17212604</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.hattersley.2005.2503">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashcroft</surname>
                    <given-names>FM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.</article-title>
                <source>Diabetes</source>
                <volume>54</volume>
                <fpage>2503</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">16123337</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.houghton.2016.2810">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Houghton</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swift</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw-Smith</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Franco</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caswell</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hussain</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohamed</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdulrasoul</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Isolated pancreatic aplasia due to hypomorphic <italic toggle="yes">PTF1A</italic> mutation.</article-title>
                <source>Diabetes.</source>
                <year>2016</year>
                <volume>65</volume>
                <fpage>2810</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">27284104</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.huopio.2003.301">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huopio</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otonkoski</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vauhkonen</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reimann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashcroft</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laakso</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1.</article-title>
                <source>Lancet</source>
                <volume>361</volume>
                <fpage>301</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12559865</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.hussain.2010.179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hussain</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Mutations in pancreatic &#x000df;-cell Glucokinase as a cause of hyperinsulinaemic hypoglycaemia and neonatal diabetes mellitus.</article-title>
                <source>Rev Endocr Metab Disord.</source>
                <volume>11</volume>
                <fpage>179</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">20878480</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.izumi.2003.409">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Izumi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokota-Hashimoto</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halban</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeuchi</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse.</article-title>
                <source>Diabetes</source>
                <volume>52</volume>
                <fpage>409</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">12540615</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.kawaguchi.2002.128">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kawaguchi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gannon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ray</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>CV</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors.</article-title>
                <source>Nat Genet</source>
                <volume>32</volume>
                <fpage>128</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">12185368</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.kim.2012.193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeda</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hom</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jetten</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Glis 3 regulates neurogenin 3 expression in pancreatic &#x000df;-cells and interacts with its activator, Hnf6.</article-title>
                <source>Mol Cells</source>
                <volume>34</volume>
                <fpage>193</fpage>
                <lpage>200</lpage>
                <pub-id pub-id-type="pmid">22820919</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.koster.2008.1054">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koster</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cadario</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peruzzi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colombo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nichols</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbetti</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>93</volume>
                <fpage>1054</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">18073297</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.lango_allen.2011.20">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lango Allen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw-Smith</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Franco</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akerman</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caswell</surname>
                    <given-names>R</given-names>
                  </name>
                  <collab>International Pancreatic Agenesis Consortium</collab>
                </person-group>
                <article-title>Ferrer J, Hattersley AT, Ellard S. GATA6 haploinsufficiency causes pancreatic agenesis in humans.</article-title>
                <source>Nat Genet.</source>
                <year>2011</year>
                <volume>44</volume>
                <fpage>20</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">22158542</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.masia.2007a.1357">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Masia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Leon</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacMullen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKnight</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanley</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nichols</surname>
                    <given-names>CG</given-names>
                  </name>
                </person-group>
                <year>2007a</year>
                <article-title>A mutation in the TMD0-L0 region of sulfonylurea receptor-1 (L225P) causes permanent neonatal diabetes mellitus (PNDM).</article-title>
                <source>Diabetes</source>
                <volume>56</volume>
                <fpage>1357</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">17317760</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.masia.2007b.328">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Masia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koster</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tumini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiarelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colombo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nichols</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbetti</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2007b</year>
                <article-title>An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.</article-title>
                <source>Diabetes</source>
                <volume>56</volume>
                <fpage>328</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">17259376</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.massa.2005.22">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Massa</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iafusco</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Amato</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquino</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dammacco</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zanette</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meschi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porzio</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bottazzo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cerutti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbetti</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.</article-title>
                <source>Hum Mutat</source>
                <volume>25</volume>
                <fpage>22</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15580558</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.matschinsky.2002.s394">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matschinsky</surname>
                    <given-names>FM</given-names>
                  </name>
                </person-group>
                <article-title>Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics.</article-title>
                <source>Diabetes.</source>
                <year>2002</year>
                <month>Dec</month>
                <volume>51</volume>
                <supplement>Suppl 3</supplement>
                <fpage>S394</fpage>
                <lpage>404</lpage>
                <pub-id pub-id-type="pmid">12475782</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.metz.2002.483">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Metz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cave</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deffert</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gueguen-Giroux</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czernichow</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polak</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases.</article-title>
                <source>J Pediatr</source>
                <volume>141</volume>
                <fpage>483</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12378186</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.mohamadi.2010.203">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mohamadi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipkin</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahone</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wodka</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plotnick</surname>
                    <given-names>LP</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM.</article-title>
                <source>Pediatr Diabetes</source>
                <volume>11</volume>
                <fpage>203</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19686306</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.moretti.2008.483">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moretti</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rezvani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koren</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Safety of glyburide for gestational diabetes: a metab-analysis of pregnancy outcomes.</article-title>
                <source>Ann Pharmacother</source>
                <volume>42</volume>
                <fpage>483</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">18349305</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.nicolino.2010.733">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nicolino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claiborn</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sen&#x000e9;e</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boland</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoffers</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julier</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>A novel hypomorphic PDX1 mutation responsible for permanent neonatal diabetes with subclinical exocrine deficiency.</article-title>
                <source>Diabetes</source>
                <volume>59</volume>
                <fpage>733</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">20009086</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.nielsen.2003.573">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nielsen</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carstensen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Echwald</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drivsholm</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glumer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorsteinsson</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borch-Johnsen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedersen</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes.</article-title>
                <source>Diabetes</source>
                <volume>52</volume>
                <fpage>573</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12540638</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.nj_lstad.2003.2854">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nj&#x000f8;lstad</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sagen</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bj&#x000f8;rkhaug</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odili</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shehadeh</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakry</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarici</surname>
                    <given-names>SU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alpay</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molnes</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molven</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000f8;vik</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matschinsky</surname>
                    <given-names>FM</given-names>
                  </name>
                </person-group>
                <article-title>Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway.</article-title>
                <source>Diabetes.</source>
                <year>2003</year>
                <volume>52</volume>
                <fpage>2854</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">14578306</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.nj_lstad.2001.1588">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nj&#x000f8;lstad</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000f8;vik</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cuesta-Mu&#x000f1;oz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bj&#x000f8;rkhaug</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massa</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbetti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Undlien</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiota</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magnuson</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molven</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matschinsky</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>GI</given-names>
                  </name>
                </person-group>
                <article-title>Neonatal diabetes mellitus due to complete glucokinase deficiency.</article-title>
                <source>N Engl J Med.</source>
                <year>2001</year>
                <volume>344</volume>
                <fpage>1588</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">11372010</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.patch.2007.28">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Patch</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boustred</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Mutations in the ABCC8 gene encoding the SUR1 subunit of the KATP channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal period.</article-title>
                <source>Diabetes Obes Metab</source>
                <volume>9</volume>
                <supplement>Suppl 2</supplement>
                <fpage>28</fpage>
                <lpage>39</lpage>
                <pub-id pub-id-type="pmid">17919176</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.pearson.2006.467">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pearson</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flechtner</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Njolstad</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malecki</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larkin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashcroft</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klimes</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Codner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iotova</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slingerland</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robert</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holst</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sovik</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.</article-title>
                <source>N Engl J Med</source>
                <volume>355</volume>
                <fpage>467</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">16885550</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.pinney.2011.1960">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pinney</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliver-Krasinski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ernst</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoffers</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Le&#x000f3;n</surname>
                    <given-names>DD</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Neonatal diabetes and congenital malabsorptive diarrhea attributable to a novel mutation in the human neurogenin-3 gene coding sequence.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>96</volume>
                <fpage>1960</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21490072</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.polak.2007.12">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Polak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cave</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Neonatal diabetes mellitus: a disease linked to multiple mechanisms.</article-title>
                <source>Orphanet J Rare Dis</source>
                <volume>2</volume>
                <fpage>12</fpage>
                <pub-id pub-id-type="pmid">17349054</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.polak.2008.1115">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Polak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dechaume</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cav&#x000e9;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nimri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crosnier</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sulmont</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Kerdanet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scharfmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebenthal</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Froguel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaxillaire</surname>
                    <given-names>M</given-names>
                  </name>
                  <collab>French Neonatal Diabetes Study Group</collab>
                </person-group>
                <article-title>Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group.</article-title>
                <source>Diabetes.</source>
                <year>2008</year>
                <volume>57</volume>
                <fpage>1115</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18171712</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.porter.2005.131">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Porter</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrett</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Permanent neonatal diabetes in an Asian infant.</article-title>
                <source>J Pediatr</source>
                <volume>146</volume>
                <fpage>131</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15644838</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.proks.2004.17539">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Proks</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antcliff</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lippiat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashcroft</surname>
                    <given-names>FM</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>101</volume>
                <fpage>17539</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">15583126</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.proks.2006.1793">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Proks</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnold</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruining</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larkin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colclough</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashcroft</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.</article-title>
                <source>Hum Mol Genet</source>
                <volume>15</volume>
                <fpage>1793</fpage>
                <lpage>800</lpage>
                <pub-id pub-id-type="pmid">16613899</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.raile.2011.255">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raile</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Connell</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galler</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Werther</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000fc;hnen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krude</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blankenstein</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Diabetes caused by insulin gene (INS) deletion: clinical characteristics of homozygous and heterozygous individuals.</article-title>
                <source>Eur J Endocrinol</source>
                <volume>165</volume>
                <fpage>255</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">21566073</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.rigoli.2011.103">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rigoli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lombardo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Bella</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Wolfram syndrome and WFS1 gene.</article-title>
                <source>Clin Genet</source>
                <volume>79</volume>
                <fpage>103</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">20738327</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.rohayem.2011.1503">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rohayem</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ehlers</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiedemann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holl</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oexie</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kordonouri</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salzano</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meissner</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burger</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schober</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huebner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee-Kirsh</surname>
                    <given-names>MA</given-names>
                  </name>
                  <collab>Wolfram Syndrome Diabetes Writing Group</collab>
                </person-group>
                <year>2011</year>
                <article-title>Diabetes and neurodegeneration in Wolfram syndrome: a multicenter study of phenotype and genotype.</article-title>
                <source>Diabetes Care</source>
                <volume>34</volume>
                <fpage>1503</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">21602428</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.rubiocabezas.2014.47">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rubio-Cabezas</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nj&#x000f8;lstad</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mlynarski</surname>
                    <given-names>W.</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chi</surname>
                    <given-names>DV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>ME.</given-names>
                  </name>
                </person-group>
                <article-title>The diagnosis and management of monogenic diabetes in children and adolescents.</article-title>
                <source>Pediatr Diabetes</source>
                <year>2014</year>
                <volume>15</volume>
                <fpage>47</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">25182307</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.rubiocabezas.2010.2326">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rubio-Cabezas</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minton</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kantor</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities.</article-title>
                <source>Diabetes</source>
                <volume>59</volume>
                <fpage>2326</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">20573748</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.rubiocabezas.2009.4162">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rubio-Cabezas</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patch</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minton</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hussain</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balafrej</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deeb</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchanan</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jefferson</surname>
                    <given-names>IG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mutair</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <collab>Neonatal Diabetes International Collaborative Group</collab>
                </person-group>
                <article-title>Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <year>2009</year>
                <volume>94</volume>
                <fpage>4162</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">19837917</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.schwitzgebel.2003.4398">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwitzgebel</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mamin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brun</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ritz-Laser</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaiko</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maret</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jornayvaz</surname>
                    <given-names>FR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theintz</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michielin</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melloul</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philippe</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>88</volume>
                <fpage>4398</fpage>
                <lpage>406</lpage>
                <pub-id pub-id-type="pmid">12970316</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.sellick.2004.1301">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sellick</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barker</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stolte-Dijkstra</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleischmann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coleman</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garrett</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wellauer</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodwin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlston</surname>
                    <given-names>RS</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutations in PTF1A cause pancreatic and cerebellar agenesis.</article-title>
                <source>Nat Genet</source>
                <volume>36</volume>
                <fpage>1301</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15543146</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.sen_e.2006.682">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sen&#x000e9;e</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chelala</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duchatelet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanc</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossec</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charon</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicolino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boileau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavener</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bougn&#x000e8;res</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taha</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julier</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism.</article-title>
                <source>Nat Genet.</source>
                <year>2006</year>
                <volume>38</volume>
                <fpage>682</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16715098</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.sen_e.2004.1876">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sen&#x000e9;e</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vattem</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del&#x000e9;pine</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rainbow</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haton</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lecoq</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robert</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rooman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diatloff-Zito</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michaud</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bin-Abbas</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taha</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franceschini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topaloglu</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lathrop</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrett</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicolino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wek</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julier</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Wolcott-Rallison Syndrome: clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity.</article-title>
                <source>Diabetes.</source>
                <year>2004</year>
                <volume>53</volume>
                <fpage>1876</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">15220213</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.shalev.2014.252">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shalev</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenebaum-Rakover</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horovitz</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paz</surname>
                    <given-names>VP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ye</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carmody</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Highland</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boerwinkle</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanis</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muzny</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibbs</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>GI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philipson</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greeley</surname>
                    <given-names>SAW</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Microcephaly, epilepsy, and neonatal diabetes due to compound heterozygous mutation in IER3IP1: insights into the natural history of a rare disorder.</article-title>
                <source>Pediatr Diabetes</source>
                <volume>15</volume>
                <fpage>252</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">24138066</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.shawsmith.2012.314">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shaw-Smith</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patch</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grulich-Henn</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Habeb</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hussain</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pomahacova</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matyka</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdullah</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia.</article-title>
                <source>Pediatric Diabetes</source>
                <volume>13</volume>
                <fpage>314</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">22369132</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.shawsmith.2014.2888">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shaw-Smith</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Franco</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lango Allen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batlle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borowiec</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taplin</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Alfen-van der Velden</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruz-Rojo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez de Nanclares</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miedzybrodzka</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deja</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wlodarska</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mlynarski</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>GATA4 mutations are a cause of neonatal diabetes in childhood-onset diabetes.</article-title>
                <source>Diabetes</source>
                <volume>63</volume>
                <fpage>2888</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">24696446</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.shimomura.2007.1342">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shimomura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horster</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Wet</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>NI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashcroft</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebinger</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.</article-title>
                <source>Neurology</source>
                <volume>69</volume>
                <fpage>1342</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17652641</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.slingerland.2006.2559">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Slingerland</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nuboer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadders-Algra</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruining</surname>
                    <given-names>GJ</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene.</article-title>
                <source>Diabetologia</source>
                <volume>49</volume>
                <fpage>2559</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">17047922</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.slingerland.2009.1683">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Slingerland</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shields</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruining</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noordam</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gach</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mlynarski</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births.</article-title>
                <source>Diabetologia</source>
                <volume>52</volume>
                <fpage>1683</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19499210</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.smith.2010.775">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qu</surname>
                    <given-names>HQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taleb</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kishimoto</surname>
                    <given-names>NY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheel</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patch</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabs</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynn</surname>
                    <given-names>FC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyatsuka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seerke</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000e9;sir</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eijnden</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abramowicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kacet</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weill</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renard</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gentile</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dewar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polychronakos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>German</surname>
                    <given-names>MS.</given-names>
                  </name>
                </person-group>
                <article-title>Rfx6 directs islet formation and insulin production in mice and humans.</article-title>
                <source>Nature.</source>
                <year>2010</year>
                <volume>463</volume>
                <fpage>775</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">20148032</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.solomon.2009.2543">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Solomon</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pineda-Alvarez</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balog</surname>
                    <given-names>JZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadley</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gropman</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nandagopal</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahn</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blain</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muenke</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Compound heterozygosity for mutations in PAX6 in a patient with complex brain anomaly, neonatal diabetes mellitus, and microophthalmia.</article-title>
                <source>Am J Med Genet Part A</source>
                <volume>149A</volume>
                <fpage>2543</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19876904</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.stanik.2007.1276">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stanik</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasperikova</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paskova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barak</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Javorkova</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jancova</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciljakova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hlava</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michalek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearson</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klimes</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>92</volume>
                <fpage>1276</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">17213273</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.stoffers.1997a.138">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stoffers</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Habener</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <year>1997a</year>
                <article-title>Early-onset type-II diabetes mellitus (MODY4) linked to IPF1.</article-title>
                <source>Nat Genet</source>
                <volume>17</volume>
                <fpage>138</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9326926</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.stoffers.1997b.106">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stoffers</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zinkin</surname>
                    <given-names>NT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanojevic</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Habener</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <year>1997b</year>
                <article-title>Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence.</article-title>
                <source>Nat Genet</source>
                <volume>15</volume>
                <fpage>106</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">8988180</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.st_y.2007.15040">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>St&#x000f8;y</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edghill</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ye</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paz</surname>
                    <given-names>VP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pluzhnikov</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Below</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayes</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipkind</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipton</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greeley</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patch</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steiner</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philipson</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>GI</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Insulin gene mutations as a cause of permanent neonatal diabetes.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>104</volume>
                <fpage>15040</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">17855560</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.st_y.2008.450">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>St&#x000f8;y</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greeley</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paz</surname>
                    <given-names>VP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ye</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pastore</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skowron</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipton</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cogen</surname>
                    <given-names>FR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>GI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philipson</surname>
                    <given-names>LH</given-names>
                  </name>
                  <collab>United States Neonatal Diabetes Working Group</collab>
                </person-group>
                <year>2008</year>
                <article-title>Diagnosis and treatment of neonatal diabetes: a United States experience.</article-title>
                <source>Pediatr Diabetes.</source>
                <volume>9</volume>
                <fpage>450</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18662362</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.st_y.2010.205">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>St&#x000f8;y</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steiner</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>S-Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ye</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philipson</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>GI</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene.</article-title>
                <source>Rev Endocr Metab Disord</source>
                <volume>11</volume>
                <fpage>205</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">20938745</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.thurber.2015.1430">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thurber</surname>
                    <given-names>BW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carmody</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadie</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pastore</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickens</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wroblewski</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naylor</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philipson</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greeley</surname>
                    <given-names>SAW</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Age at time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes.</article-title>
                <source>Diabetologia</source>
                <volume>58</volume>
                <fpage>1430</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">25877689</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.tjora.2013.946">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tjora</surname>
                    <given-names>E.</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wathle</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erchinger</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engjom</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molven</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aksnes</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haldorsen</surname>
                    <given-names>IS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dimcevski</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raeder</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nj&#x000f8;lstad</surname>
                    <given-names>PR</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Exocrine pancreatic function in hepatocyte nuclear factor 1beta-maturity-onset diabetes of the young (HNF1B-MODY) is only moderately reduced: compensatory hypersecretion from a hypoplastic pancreas.</article-title>
                <source>Diabet Med</source>
                <volume>30</volume>
                <fpage>946</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">23600988</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.turkkahraman.2008.122">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Turkkahraman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bircan</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tribble</surname>
                    <given-names>ND</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ak&#x000e7;urin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gloyn</surname>
                    <given-names>AL</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.</article-title>
                <source>J Pediatr.</source>
                <volume>153</volume>
                <fpage>122</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18571549</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.wang.2006.270">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cortina</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tran</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bailey</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jamrich</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ament</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Treem</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargas</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gershman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farmer</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reyen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mutant neurogenin-3 in congenital malabsorptive diarrhea.</article-title>
                <source>N Engl J Med</source>
                <volume>355</volume>
                <fpage>270</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">16855267</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.wiedemann.2010.18">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wiedemann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schober</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waldhoer</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koehle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackay</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steichen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meraner</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmerhackl</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofer</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Incidence of neonatal diabetes in Austria-calculation based on the Austrian Diabetes Register.</article-title>
                <source>Pediatr Diabetes.</source>
                <year>2010</year>
                <volume>11</volume>
                <fpage>18</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">19496964</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.yasuda.2002.224">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yasuda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kajimoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujitani</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watada</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watarai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Umayahara</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuhisa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorogawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuwayama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tano</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamasaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hori</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>PAX6 mutation as a genetic factor common to aniridia and glucose intolerance.</article-title>
                <source>Diabetes</source>
                <volume>51</volume>
                <fpage>224</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">11756345</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.yorifuji.2004.2905">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yorifuji</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurokawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mamada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shishido</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakahata</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: Phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1beta gene due to germline mosaicism.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <year>2004</year>
                <volume>89</volume>
                <fpage>2905</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15181075</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.zeruth.2013.1692">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zeruth</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeda</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jetten</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <article-title>The Kr&#x000fc;ppel-like protein Gli-similar 3 (Glis3) functions as a key regulator of insulin transcription.</article-title>
                <source>Mol Endocrinol.</source>
                <year>2013</year>
                <volume>27</volume>
                <fpage>1692</fpage>
                <lpage>705</lpage>
                <pub-id pub-id-type="pmid">23927931</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="dmn.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="dmn.Suggested_Reading.reflist0">
            <ref id="dmn.REF.greeley.2011.622">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Greeley</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winn</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ornelas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipton</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philipson</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>GI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>ES</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes.</article-title>
                <source>Diabetes Care.</source>
                <year>2011</year>
                <volume>34</volume>
                <fpage>622</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21273495</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.murphy.2008.200">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes.</article-title>
                <source>Nat Clin Pract Endocrinol Metab.</source>
                <volume>4</volume>
                <fpage>200</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">18301398</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.rubiocabezas.2013.137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rubio-Cabezas</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Diabetes mellitus in neonates and infants: genetic heterogeneity, clinical approach to diagnosis, and therapeutic options.</article-title>
                <source>Horm Res Paediatr.</source>
                <volume>80</volume>
                <fpage>137</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">24051999</pub-id>
              </element-citation>
            </ref>
            <ref id="dmn.REF.shield.2000.7">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Neonatal diabetes: new insights into aetiology and implications.</article-title>
                <source>Horm Res.</source>
                <volume>53</volume>
                <supplement>Suppl 1</supplement>
                <fpage>7</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">10895036</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="dmn.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="dmn.Acknowledgments">
          <title>Acknowledgments</title>
          <p>The authors receive grant support from NIH grants R01DK098517 and R01FD004095 (DDDL); and R37DK056268 (CAS).</p>
        </sec>
        <sec id="dmn.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>29 July 2016 (sw) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>23 January 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>5 July 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>4 March 2008 (cd) Revision: sequence analysis and prenatal diagnosis available for INS mutations</p>
            </list-item>
            <list-item>
              <p>8 February 2008 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>9 August 2007 (cas) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
